Search filters

List of works by Ronald N Jones

10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America

scientific article

1454Antifungal Susceptibility Patterns of a Global Collection of Fungal Isolates and Polysorbate-80 Effect on the Susceptibility of the Antifungal Classes.

scientific article

1534. Polymyxin Antimicrobial Susceptibility (AST) Testing and Breakpoints for P. aeruginosa, A. baumannii, and Enterobacteriaceae: Recommendations from the United States Committee on Antimicrobial Susceptibility Testing (USCAST)

1590. Updated Aminoglycoside (AG) MIC Breakpoints (BP) to Minimize Adverse Events and Improve Outcome: Impact on Susceptibility (S) Rates

scientific article published on 23 October 2019

1591. Updated Fluoroquinolone MIC Breakpoints: Impact on Susceptibility Rates in the United States

247Antimicrobial Activity of Ceftolozane/Tazobactam Tested against Gram-negative Bacterial Isolates from Hospitalized Patients with Pneumonia in United States Hospitals (2013).

scientific article

250Ceftazidime-avibactam Activity Tested Against a Large Collection of Enterobacteriaceae Isolates Collected in United States (USA) Hospitals in the 2011-2013 Period, Including Organisms Producing KPC- and CTX-M-variants.

scientific article

2562. Re-Appraisal of Aminoglycoside (AG) Susceptibility Testing Breakpoints Based on the Application of Pharmacokinetics–Pharmacodynamics (PK-PD) and Contemporary Microbiology Surveillance Data

257In Vitro Activity of Meropenem/RPX7009, a Carbapenem/β-lactamase Inhibitor Combination Tested Against Contemporary Populations of Enterobacteriaceae and KPC-producing Strains.

scientific article

3-0-demethyl fortimicin A: in vitro activity and interpretive zone standards for disk diffusion susceptibility tests.

scientific article

410Tracking Linezolid Antimicrobial Activity and Resistance in North America: Results from LEADER 2013 Program.

scientific article published in December 2014

470Oritavancin Activity Against Gram-positive Clinical Isolates Responsible for Documented Skin and Skin Structure Infections in USA and European Hospitals (2012-2013).

scientific article

475Telavancin (TLV) In vitro Activity Tested Against a USA Collection of Methicillin-resistant Staphylococcus aureus (MRSA), Including a Multidrug-resistant (MDR) Subset (2011-2013).

scientific article published in December 2014

729Activity of Ceftaroline and Comparator Agents Tested against Staphylococcus aureus from Patients with Bacteremia in United States (USA) Medical Centers (2009-2013).

scientific article

811Antimicrobial activity of ceftaroline tested against respiratory tract infection (RTI) pathogens isolated from USA medical centers in 2013.

scientific article

A 1994-95 survey of Haemophilus influenzae susceptibility to ten orally administered agents. A 187 clinical laboratory center sample in the United States

scientific article

A Cluster of Serious Escherichia coli Infections in a Neonatal Intensive-Care Unit

scholarly article by Daniel J. Diekema et al published November 1997 in Infection Control and Hospital Epidemiology

A cluster of serious Escherichia coli infections in a neonatal intensive-care unit

scientific article published on 01 November 1997

A comparison of the antimicrobial activity of meropenem and selected broad-spectrum antimicrobials tested against multi-drug resistant Gram-negative bacilli including bacteraemic Salmonella spp.: initial studies for the MYSTIC programme in India

scientific article published in December 2002

A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp.

scientific article

A multicenter evaluation of linezolid antimicrobial activity in North America

scientific article published in May 2002

A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia

scientific article

A pragmatic approach to identify extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in Taiwan: in vitro activity of newer and established antimicrobial agents

scientific article published in April 2004

A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world wide ⬇️

scientific article published on August 1, 1997

A simple stacked disc technique for testing bacterial susceptibility to antimicrobial agents in combination with sulbactam

scientific article published on 01 December 1989

A three category system for interpretation of disk tests for Pseudomonas-active penicillins and beta-lactamase hydrolysis/inhibition studies

scientific article published on 01 January 1982

AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States

scientific article published in September 2012

AZD2563, a new oxazolidinone: bactericidal activity and synergy studies combined with gentamicin or vancomycin against staphylococci and streptococcal strains

scientific article published in May 2002

Ability of Latin America laboratories to detect antimicrobial resistance patterns: experience of the SENTRY antimicrobial surveillance program (1997-2000) ⬇️

scientific article published on January 22, 2004

Ability of the modified Vitek card to detect coagulase-negative staphylococcal with mecA and Oxacillin-resistant phenotypes

scientific article published on June 1999

Accuracy of broth microdilution and E test methods for detecting chloramphenicol acetyl transferase mediated resistance in Streptococcus pneumoniae: Geographic variations in the prevalence of resistance in The SENTRY Antimicrobial Surveillance Progr

scientific article published in April 2001

Accuracy of cefepime antimicrobial susceptibility testing results for Pseudomonas aeruginosa tested on the MicroScan WalkAway System

scientific article

Accuracy of the Thermo Fisher Scientific (Sensititre™) dry-form broth microdilution MIC product when testing ceftaroline

scientific article published on 30 December 2014

Accuracy of the Vitek system for antimicrobial susceptibility testing Enterobacteriaceae bloodstream infection isolates: use of “direct” inoculation from Bactec 9240 blood culture bottles ⬇️

scientific article published on June 1, 1997

Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum beta-lactam agents

scientific article

Accurate characterization of ofloxacin susceptibility with Enterobacteriaceae using a modified GNS F6 card and the bioMerieux Vitek System

scientific article published on 01 July 1996

Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods

scientific article published on 14 November 2011

Activities of Tedizolid and Linezolid Determined by the Reference Broth Microdilution Method against 3,032 Gram-Positive Bacterial Isolates Collected in Asia-Pacific, Eastern Europe, and Latin American Countries in 2014.

scientific article published on 27 June 2016

Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi

scientific article published in August 2003

Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates

scientific article published on 5 January 2009

Activities of doripenem (S-4661) against drug-resistant clinical pathogens

scientific article published on August 2004

Activity analyses of staphylococcal isolates from pediatric, adult, and elderly patients: AWARE Ceftaroline Surveillance Program

scientific article published in September 2012

Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998).

scientific article

Activity and spectrum of BMS 284756, a new des-F (6) quinolone, tested against strains of ciprofloxacin-resistant Gram-positive cocci

scientific article published in February 2001

Activity of BMS284756 (T-3811) tested against anaerobic bacteria, Campylobacter jejuni, Helicobacter pylori and Legionella spp.

scientific article published in May 2001

Activity of BMS284756 against 2,681 recent clinical isolates of Haemophilus influenzae and Moraxella catarrhalis: Report from The SENTRY Antimicrobial Surveillance Program (2000) in Europe, Canada and the United States

scientific article published in April 2001

Activity of DX-619 compared to other agents against viridans group streptococci, Streptococcus bovis, and Cardiobacterium hominis

scientific article

Activity of Debio1452, a FabI inhibitor with potent activity against Staphylococcus aureus and coagulase-negative Staphylococcus spp., including multidrug-resistant strains

scientific article published on 17 February 2015

Activity of Fusidic Acid Tested against Staphylococci Isolated from Patients in U.S. Medical Centers in 2014.

scientific article

Activity of JNJ-Q2 against Staphylococcus aureus isolated from patients with acute bacterial skin and skin-structure infection obtained during a Phase 2 clinical trial

scientific article published on 20 July 2012

Activity of JNJ-Q2, a new fluoroquinolone, tested against contemporary pathogens isolated from patients with community-acquired bacterial pneumonia ⬇️

scientific article published on February 4, 2012

Activity of JNJ-Q2, a novel fluoroquinolone, tested against Neisseria gonorrhoeae, including ciprofloxacin-resistant strains ⬇️

scientific article published on July 21, 2012

Activity of MK-0991 (l-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp ⬇️

scientific article published on 01 September 1998

Activity of MK-3118, a new oral glucan synthase inhibitor, tested against Candida spp. by two international methods (CLSI and EUCAST)

scientific article published on 28 November 2012

Activity of Plazomicin Tested against Enterobacterales Isolates Collected from U.S. Hospitals (2016-2017): Effect of Different Breakpoint Criteria on in the Susceptibility Rates among Aminoglycosides

scientific article published on 24 February 2020

Activity of a broad-spectrum cephalosporin (Ro 48-8391) alone and in combination with two novel beta-lactamase inhibitors (Ro 48-5545 and Ro 48-8724)

scientific article published on 01 October 1998

Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates

scientific article published on 10 June 2016

Activity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiae

scientific article

Activity of a peptide deformylase inhibitor LBM415 (NVP PDF-713) tested against recent clinical isolates from Japan

scientific article published on 13 January 2005

Activity of cefepime (BMY-28142) and cefpirome (HR 810) against gram-negative bacilli resistant to cefotaxime or ceftazidime

scientific article published on 01 January 1989

Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States

scientific article published on 22 March 2010

Activity of ceftaroline and comparator agents tested against Staphylococcus aureus from patients with bloodstream infections in US medical centres (2009-13).

scientific article published on 25 March 2015

Activity of ceftaroline and comparator agents tested against contemporary Gram-positive and -negative (2011) isolates collected in Europe, Turkey, and Israel

scientific article published on 6 December 2013

Activity of ceftaroline-avibactam tested against Gram-negative organism populations, including strains expressing one or more β-lactamases and methicillin-resistant Staphylococcus aureus carrying various staphylococcal cassette chromosome mec types

scientific article published on 25 June 2012

Activity of ceftaroline-avibactam tested against contemporary Enterobacteriaceae isolates carrying β-lactamases prevalent in the United States

scientific article published on 4 March 2014

Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types

scientific article

Activity of contemporary antifungal agents, including the novel echinocandin anidulafungin, tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007).

scientific article published on 22 April 2009

Activity of dalbavancin tested against Staphylococcus spp. and beta-hemolytic Streptococcus spp. isolated from 52 geographically diverse medical centers in the United States

scientific article published on 10 January 2007

Activity of daptomycin against gram-positive bacterial isolates from Indian medical centres (2006-2007).

scientific article published on 19 July 2009

Activity of daptomycin and selected antimicrobial agents tested against Staphylococcus aureus from patients with bloodstream infections hospitalized in European medical centers

scientific article

Activity of echinocandins and triazoles against a contemporary (2012) worldwide collection of yeast and moulds collected from invasive infections

scientific article published on 23 July 2014

Activity of faropenem tested against Neisseria gonorrhoeae isolates including fluoroquinolone-resistant strains

scientific article published on 2 November 2005

Activity of garenoxacin, an investigational des-F(6)-quinolone, tested against pathogens from community-acquired respiratory tract infections, including those with elevated or resistant-level fluoroquinolone MIC values

scientific article published on 03 April 2007

Activity of gatifloxacin against Haemophilus influenzae and Moraxella catarrhalis, including susceptibility test development, E-test comparisons, and quality control guidelines for H. influenzae.

scientific article

Activity of gatifloxacin tested against isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (North America, 1998-2003).

scientific article published on 9 March 2006

Activity of gemifloxacin tested against Neisseria gonorrhoeae isolates including antimicrobial-resistant phenotypes

scientific article published on 19 January 2006

Activity of linezolid against 3,251 strains of uncommonly isolated gram-positive organisms: report from the SENTRY Antimicrobial Surveillance Program

scientific article

Activity of macrolides, lincosamines, streptogramins and fluoroquinolones against streptococcus pneumoniae and enterococci isolates from the western hemisphere: example of international surveillance (SENTRY antimicrobial surveillance program )in the

scientific article published on 01 February 2000

Activity of meropenem as serine carbapenemases evolve in US Medical Centers: monitoring report from the MYSTIC Program (2006).

scientific article published on 26 July 2007

Activity of mupirocin and 14 additional antibiotics against staphylococci isolated from Latin American hospitals: report from the SENTRY antimicrobial surveillance program

scientific article

Activity of oritavancin against Gram-positive clinical isolates responsible for documented skin and soft-tissue infections in European and US hospitals (2010-13).

scientific article published on 31 October 2014

Activity of oritavancin tested against uncommonly isolated Gram-positive pathogens responsible for documented infections in hospitals worldwide

scientific article published on 5 February 2014

Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant gram-positive cocci

scientific article

Activity of six contemporary antibacterial agents against 96 isolates from purulent meningitis: the contribution of desacetylcefotaxime to antimicrobial potency

scientific article published on 01 June 1987

Activity of telavancin against Gram-positive pathogens isolated from bone and joint infections in North American, Latin American, European and Asia-Pacific nations

scientific article published on 8 March 2017

Activity of telavancin and comparator antimicrobial agents tested against Staphylococcus spp. isolated from hospitalised patients in Europe (2007-2008).

scientific article published on 3 July 2010

Activity of temocillin and ticarcillin against consecutively isolated Enterobacteriaceae in four medical centres

scientific article published on 01 April 1986

Activity of the quinupristin-dalfopristin combination (RP-59500; Synercid) tested against vancomycin-resistant Enterococcus species

scientific article published on 01 January 1996

Activity of tigecycline tested against a global collection of Enterobacteriaceae, including tetracycline-resistant isolates

scientific article published in July 2005

Activity of two novel fluoroquinolones (DU-6859a and DV-7751a) tested against glycopeptide-resistant enterococcal isolates

scientific article published on 01 November 1995

Age-related trends in pathogen frequency and antimicrobial susceptibility of bloodstream isolates in North America: SENTRY Antimicrobial Surveillance Program, 1997-2000.

scientific article published in December 2002

Ampicillin-resistant Haemophilus paraphrophilus laryngo-epiglottitis

scientific article published on November 1976

An in vitro evaluation of HRE 664, a novel penem antibiotic

scientific article published in September 1988

An international activity and spectrum analysis of linezolid: ZAAPS Program results for 2011.

scientific article published on 9 March 2013

Analysis of 5-year trends in daptomycin activity tested against Staphylococcus aureus and enterococci from European and US hospitals (2009-2013).

scientific article published on 22 May 2015

Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).

scientific article

Analysis of Vancomycin Susceptibility Testing Results for Presumptive Categorization of Telavancin

scientific article

Antagonism between penicillin and erythromycin against Streptococcus pneumoniae: does it exist?

scientific article published on 01 July 2003

Anti-Legionella activity of trovafloxacin compared with seven other antimicrobial agents including an intermethod evaluation ⬇️

scientific article published on 01 September 1997

Anti-gonococcal activity of gemifloxacin against fluoroquinolone-resistant strains and a comparison of agar dilution and Etest methods

scientific article published in April 2000

Anti-streptococcal activity of SB-265805 (LB20304), a novel fluoronaphthyridone, compared with five other compounds, including quality control guidelines

scientific article published on 01 February 1999

Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid ⬇️

scientific article published on May 1, 1984

Antibacterial activity of 41 antimicrobials tested against over 2773 bacterial isolates from hospitalized patients with pneumonia: I--results from the SENTRY Antimicrobial Surveillance Program (North America, 1998).

scientific article published in February 2001

Antibacterial activity of fortimicin A compared with those of five other aminoglycosides, and factors affecting susceptibility tests

scientific article published on January 1981

Antibacterial activity of trospectomycin (U-63366F) and initial evaluations of disk diffusion susceptibility tests

scientific article

Antibiotic resistance. Epidemiology and therapeutics

scientific article published on 01 February 1992

Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance P

scientific article

Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi

scientific article published on 01 December 1998

Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans.

scientific article

Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012).

scientific article

Antigonococcal activity of 11 drugs used for therapy or prophylaxis of malaria

scientific article published on September 1995

Antimicrobial Activities of Ceftaroline and Comparator Agents against Bacterial Organisms Causing Bacteremia in Patients with Skin and Skin Structure Infections in U.S. Medical Centers, 2008 to 2014.

scientific article published on 8 February 2016

Antimicrobial Activities of Ceftazidime-Avibactam and Comparator Agents against Gram-Negative Organisms Isolated from Patients with Urinary Tract Infections in U.S. Medical Centers, 2012 to 2014.

scientific article published on 25 April 2016

Antimicrobial Activity and Spectrum Investigation of Eight Broad-Spectrum β-Lactam Drugs: A 1997 Surveillance Trial in 102 Medical Centers in the United States ⬇️

scientific article published on 01 March 1998

Antimicrobial Activity of CXA-101, a Novel Cephalosporin Tested in Combination with Tazobactam against Enterobacteriaceae, Pseudomonas aeruginosa, and Bacteroides fragilis Strains Having Various Resistance Phenotypes ⬇️

scientific article published on February 14, 2011

Antimicrobial Activity of Ceftaroline Tested against Staphylococcus aureus from Surgical Skin and Skin Structure Infections in US Medical Centers

scientific article

Antimicrobial Activity of Daptomycin Tested Against Gram-Positive Strains Collected in European Hospitals: Results from 7 Years of Resistance Surveillance (2003-2009) ⬇️

scientific article published on 01 August 2011

Antimicrobial Activity of Desacetylcefotaxime Alone and in Combination with Cefotaxime: Evidence of Synergy ⬇️

scientific article published on 01 September 1982

Antimicrobial Activity of High-Proportion Cefepime-Tazobactam (WCK 4282) against a Large Number of Gram-Negative Isolates Collected Worldwide in 2014.

scientific article published on 30 January 2017

Antimicrobial Activity of Quinupristin-Dalfopristin (RP 59500, Synercid®) Tested against Over 28,000 Recent Clinical Isolates from 200 Medical Centers in the United States and Canada ⬇️

scientific article published on July 1, 1998

Antimicrobial Activity of SCH 27899, Oligosaccharide Member of the Everninomycin Class with a Wide Gram-Positive Spectrum

scientific article

Antimicrobial Resistance Surveillance and New Drug Development

article

Antimicrobial Susceptibility Tests with Cefotaxime and Correlation with Clinical Bacteriologic Response ⬇️

scientific article published on September 1, 1982

Antimicrobial Susceptibility of Complex and Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997-2016)

Antimicrobial Susceptibility of Klebsiella pneumoniae Producing Extended-Spectrum beta-lactamase (ESBL) Isolated in Hospitals in Brazil

scientific article published on 01 August 1997

Antimicrobial Susceptibility of from North America, Europe, Latin America, and the Asia-Pacific Region: Results From 20 Years of the SENTRY Antimicrobial Surveillance Program (1997-2016)

article

Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus

scientific article

Antimicrobial activities of doripenem and other carbapenems against Pseudomonas aeruginosa, other nonfermentative bacilli, and Aeromonas spp.

scientific article published on 26 February 2009

Antimicrobial activities of garenoxacin (BMS 284756) against Asia-Pacific region clinical isolates from the SENTRY program, 1999 to 2001.

scientific article

Antimicrobial activities of piperacillin-tazobactam against Haemophilus influenzae isolates, including beta-lactamase-negative ampicillin-resistant and beta-lactamase-positive amoxicillin-clavulanate-resistant isolates, and mutations in their quinol

scientific article published on 03 August 2009

Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program

scientific article

Antimicrobial activity against strains of Escherichia coli and Klebsiella spp. with resistance phenotypes consistent with an extended-spectrum beta-lactamase in Europe

scientific article published on July 2003

Antimicrobial activity and disk diffusion susceptibility testing of U-76,253A (R-3746), the active metabolite of the new cephalosporin ester, U-76,252 (CS-807)

scientific article

Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species

scientific article published in June 2000

Antimicrobial activity and other in vitro properties of cefoperazone A, the principal metabolite of cefoperazone sodium

scientific article published on August 1983

Antimicrobial activity and spectrum of LY146032, a lipopeptide antibiotic, including susceptibility testing recommendations

scientific article published on April 1987

Antimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strains

scientific article

Antimicrobial activity and spectrum of SCH27899 (Ziracin) tested against gram-positive species including recommendations for routine susceptibility testing methods and quality control. Quality Control Study Group

scientific article

Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates

scientific article published on 01 January 1980

Antimicrobial activity and spectrum of daptomycin: results from the surveillance program in Australia and New Zealand (2008).

scientific article published on January 2010

Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative

scientific article

Antimicrobial activity and spectrum of sparfloxacin tested against erythromycin-resistant Streptococcus pneumoniae isolates

scientific article published on 01 February 1996

Antimicrobial activity evaluations of gatifloxacin, a new fluoroquinolone: contemporary pathogen results from a global antimicrobial resistance surveillance program (SENTRY, 1997).

scientific article

Antimicrobial activity evaluations of two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628.

scientific article

Antimicrobial activity of 11 newer and investigational drugs tested against aerobic isolates from spontaneous bacterial peritonitis ⬇️

scientific article published on 01 February 1995

Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-Enteric Gram-negative bacilli: Occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes ⬇️

scientific article published on November 1, 1997

Antimicrobial activity of BMS 284756 (T-3811) against Neisseria gonorrhoeae tested by three methods ⬇️

scientific article published on November 1, 2001

Antimicrobial activity of DC-159a, a new fluoroquinolone, against 1,149 recently collected clinical isolates

scientific article published on 23 June 2008

Antimicrobial activity of E-1040, a novel thiadiazolyl cephalosporin compared with other parenteral cephems

scientific article

Antimicrobial activity of FK-037 against class I beta-lactamase producing species resistant to ceftazidime: a multi-laboratory clinical isolate sample

scientific article

Antimicrobial activity of FK-037, a new broad-spectrum cephalosporin. International in vitro comparison with cefepime and ceftazidime

scientific article published in March 1994

Antimicrobial activity of HR810 against 419 strict anaerobic bacteria

scientific article published on March 1985

Antimicrobial activity of LB10827, a new orally administered cephalosporin, tested against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae ⬇️

scientific article published on August 1, 2003

Antimicrobial activity of LB20304, a fluoronaphthyridone, tested against anaerobic bacteria ⬇️

scientific article published on 01 October 1997

Antimicrobial activity of LBM415 (NVP PDF-713) tested against pathogenic Neisseria spp. (Neisseria gonorrhoeae and Neisseria meningitidis).

scientific article published in February 2005

Antimicrobial activity of MDL 19,592: an oral cephalosporin

scientific article published in November 1988

Antimicrobial activity of RU-66647, a new ketolide

scientific article published on 01 January 1997

Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolates

scientific article published on December 1986

Antimicrobial activity of Ro 19-5247 (T-2525), a new oral cephalosporin, tested against 7,745 recent clinical isolates

scientific article published on 01 March 1987

Antimicrobial activity of Ro 23-9424, a novel ester-linked codrug of fleroxacin and desacetylcefotaxime

scientific article

Antimicrobial activity of SCH27899 (Ziracin), a novel everninomicin derivative, tested against Streptococcus spp.: disk diffusion/etest method evaluations and quality control guidelines. The Quality Control Study Group

scientific article

Antimicrobial activity of a new antipseudomonal dual-action drug, Ro 25-0534.

scientific article

Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).

scientific article published on 20 March 2006

Antimicrobial activity of advanced-spectrum fluoroquinolones tested against more than 2000 contemporary bacterial isolates of species causing community-acquired respiratory tract infections in the United States (1999).

scientific article

Antimicrobial activity of amikacin combinations against Enterobacteriaceae moderately susceptible to third-generation cephalosporins

scientific article published on December 1982

Antimicrobial activity of broad-spectrum agents tested against Gram-negative bacilli resistant to ceftazidime: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).

scientific article published in December 2002

Antimicrobial activity of cefditoren tested against contemporary (2004-2006) isolates of Haemophilus influenzae and Moraxella catarrhalis responsible for community-acquired respiratory tract infections in the United States

scientific article

Antimicrobial activity of cefepime tested against Bush group I beta-lactamase-producing strains resistant to ceftazidime. A multilaboratory national and international clinical isolate study

scientific article published in May 1994

Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).

scientific article published on 2 May 2006

Antimicrobial activity of cefmetazole (CS-1170) and recommendations for susceptibility testing by disk diffusion, dilution, and anaerobic methods

scientific article published on December 1986

Antimicrobial activity of cefotaxime tested against infrequently isolated pathogenic species (unusual pathogens) ⬇️

scientific article published on May 1, 1995

Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centers

scientific article

Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010).

scientific article published on 25 March 2013

Antimicrobial activity of ceftaroline and comparator agents when tested against numerous species of coagulase-negative Staphylococcus causing infection in US hospitals

scientific article

Antimicrobial activity of ceftaroline combined with avibactam tested against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2010-2012).

scientific article

Antimicrobial activity of ceftaroline tested against bacterial isolates causing respiratory tract and skin and skin structure infections in US medical centers in 2013.

scientific article published on 10 February 2015

Antimicrobial activity of ceftaroline tested against drug-resistant subsets of Streptococcus pneumoniae from U.S. medical centers

scientific article published on 10 February 2014

Antimicrobial activity of ceftaroline tested against staphylococci with reduced susceptibility to linezolid, daptomycin, or vancomycin from U.S. hospitals, 2008 to 2011.

scientific article published on 29 April 2013

Antimicrobial activity of ceftaroline-avibactam tested against clinical isolates collected from U.S. Medical Centers in 2010-2011.

scientific article

Antimicrobial activity of ceftazidime-avibactam against Gram-negative organisms collected from U.S. medical centers in 2012.

scientific article

Antimicrobial activity of ceftazidime-avibactam and comparator agents when tested against bacterial isolates causing infection in cancer patients (2013-2014).

scientific article published on 29 November 2016

Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006).

scientific article published on 2 April 2008

Antimicrobial activity of ceftolozane-tazobactam tested against Enterobacteriaceae and Pseudomonas aeruginosa with various resistance patterns isolated in U.S. Hospitals (2011-2012).

scientific article published on 07 October 2013

Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011-12)

scientific article published on 10 June 2014

Antimicrobial activity of ceftriaxone, cefotaxime, desacetylcefotaxime, and cefotaxime-desacetylcefotaxime in the presence of human serum

scientific article published on May 1987

Antimicrobial activity of coumermycin and recommendations for disk diffusion tests with 5- and 15-micrograms disks

scientific article

Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centres

scientific article

Antimicrobial activity of daptomycin against multidrug-resistant Gram-positive strains collected worldwide

scientific article published in November 2004

Antimicrobial activity of daptomycin and selected comparators tested against bloodstream Staphylococcus aureus isolates from hemodialysis patients

scientific article

Antimicrobial activity of daptomycin in comparison to glycopeptides and other antimicrobials when tested against numerous species of coagulase-negative Staphylococcus

scientific article published on 01 June 2012

Antimicrobial activity of daptomycin tested against Gram-positive pathogens collected in Europe, Latin America, and selected countries in the Asia-Pacific Region (2011).

scientific article published in April 2013

Antimicrobial activity of daptomycin tested against Staphylococcus aureus with vancomycin MIC of 2 microg/mL isolated in the United States and European hospitals (2006-2008).

scientific article published in March 2010

Antimicrobial activity of daptomycin tested against clinical strains of indicated species isolated in North American medical centers (2003).

scientific article published on 2 November 2005

Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003).

scientific article published in December 2005

Antimicrobial activity of doripenem tested against prevalent Gram-positive pathogens: results from a global surveillance study (2003-2007).

scientific article published in April 2009

Antimicrobial activity of gatifloxacin (AM-1155, CG5501), and four other fluoroquinolones tested against 2,284 recent clinical strains of Streptococcus pneumoniae from Europe, Latin America, Canada, and the United States. The SENTRY Antimicrobial Su

scientific article published on 01 August 1999

Antimicrobial activity of gatifloxacin compared to seven other compounds tested against gram-positive organisms isolated at 10 cancer-treatment centers

scientific article published in May 1999

Antimicrobial activity of gatifloxacin tested against 1676 strains of ciprofloxacin-resistant gram-positive cocci isolated from patient infections in North and South America

scientific article

Antimicrobial activity of gatifloxacin tested against Neisseria gonorrhoeae using three methods and a collection of fluoroquinolone-resistant strains

scientific article published on 01 December 1998

Antimicrobial activity of imipenem and SCH34343 against Legionella species

scientific article published on 01 April 1987

Antimicrobial activity of linezolid against Gram-positive cocci isolated in Brazil ⬇️

scientific article published on March 7, 2003

Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infections

scientific article

Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infections

scientific article

Antimicrobial activity of prulifloxacin tested against a worldwide collection of gastroenteritis-producing pathogens, including those causing traveler's diarrhea

scientific article

Antimicrobial activity of solithromycin against serotyped macrolide-resistant Streptococcus pneumoniae isolates collected from U.S. medical centers in 2012.

scientific article published on 20 January 2015

Antimicrobial activity of the investigational pleuromutilin compound BC-3781 tested against Gram-positive organisms commonly associated with acute bacterial skin and skin structure infections

scientific article published on 9 January 2012

Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugs

scientific article

Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs) ⬇️

scientific article published on January 27, 2012

Antimicrobial activity of the novel polymyxin derivative NAB739 tested against Gram-negative pathogens

scientific article published on 6 November 2012

Antimicrobial activity of the pleuromutilin antibiotic BC-3781 against bacterial pathogens isolated in the SENTRY antimicrobial surveillance program in 2010.

scientific article published on 8 July 2013

Antimicrobial activity of tigecycline (GAR-936) tested against 3498 recent isolates of Staphylococcus aureus recovered from nosocomial and community-acquired infections

scientific article published in December 2004

Antimicrobial activity of tigecycline against community-acquired methicillin-resistant Staphylococcus aureus isolates recovered from North American medical centers

scientific article published on 18 December 2007

Antimicrobial activity of tigecycline and cefoperazone/sulbactam tested against 18,386 Gram-negative organisms from Europe and the Asia-Pacific region (2013-2014).

scientific article

Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit

scientific article published in July 2005

Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia

scientific article published in July 2005

Antimicrobial activity of trovafloxacin tested against ciprofloxacin-susceptible and -resistant Neisseria gonorrhoeae interpretive criteria and comparisons with Etest results ⬇️

scientific article published on 01 August 1997

Antimicrobial activity, beta-lactamase stability and beta-lactamase inhibition of cefotetan and other 7-alpha-methoxy beta-lactam antimicrobials.

scientific article

Antimicrobial activity, spectrum, and recommendations for disk diffusion susceptibility testing of ceftibuten (7432-S; SCH 39720), a new orally administered cephalosporin

scientific article published on October 1988

Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates

scientific article

Antimicrobial characteristics of quinupristin/dalfopristin (Synercid at 30:70 ratio) compared to alternative ratios for in vitro testing

scientific article published in April 1997

Antimicrobial interactions (Synergy) of teicoplanin with two broad-spectrum drugs (cefotaxime, ofloxacin) tested against Gram-positive isolates from Germany and the United States ⬇️

scientific article published on 01 October 1997

Antimicrobial interactions of trovafloxacin and extended-spectrum cephalosporins or azithromycin tested against clinical isolates of Pseudomonas aeruginosa and Stenotrophomonas maltophilia

scientific article published on 01 October 1998

Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010).

scientific article published on 31 May 2012

Antimicrobial resistance among Gram-positive bacteria isolated in Latin American hospitals

scientific article published in December 2009

Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program

scientific article published on 26 March 2007

Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America

scientific article published in March 2001

Antimicrobial resistance rates and clonality results from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) programme: report of year five (2003).

scientific article

Antimicrobial resistance trends in community-acquired respiratory tract pathogens in the Western Pacific Region and South Africa: report from the SENTRY antimicrobial surveillance program, (1998-1999) including an in vitro evaluation of BMS284756.

scientific article published in February 2002

Antimicrobial resistance trends in medical centers using carbapenems: report of 1999 and 2000 results from the MYSTIC program (USA) ⬇️

scientific article published on December 1, 2001

Antimicrobial spectrum and activity of NVP PDF-713, a novel peptide deformylase inhibitor, tested against 1,837 recent Gram-positive clinical isolates

scientific article published on 01 May 2004

Antimicrobial spectrum and potency of dalbavancin tested against clinical isolates from Europe and North America (2003): initial results from an international surveillance protocol

scientific article published in December 2005

Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials: report from the MYSTIC Program (2002) in North America

scientific article published in September 2003

Antimicrobial spectrum of cefpirome combined with tazobactam against the Bacteroides fragilis group

scientific article published on 01 September 1990

Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S. maltophilia infections

scientific article published on 5 April 2010

Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997-2001).

scientific article

Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY Antimicrobial Surveillance Program, 2009-2012

scientific article published on 07 February 2014

Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011).

scientific article

Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008).

scientific article published in October 2009

Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004)

scientific article published on 24 May 2007

Antimicrobial susceptibility of Gram-positive cocci isolated from skin and skin-structure infections in European medical centres

scientific article published on 4 May 2010

Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program

scientific article

Antimicrobial susceptibility of bacteria causing urinary tract infections in Latin American hospitals: results from the SENTRY Antimicrobial Surveillance Program (1997).

scientific article

Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005–2010) ⬇️

scientific article published on 04 May 2011

Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004)

scientific article published on 01 September 2006

Antimicrobial susceptibility of inducible AmpC beta-lactamase-producing Enterobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme, Europe 1997-2000.

scientific article published in May 2002

Antimicrobial susceptibility of quinupristin/dalfopristin tested against gram-positive cocci from Latin America: results from the global SMART (GSMART) surveillance study

scientific article published on February 2001

Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli

scientific article

Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA).

scientific article

Antimicrobial susceptibility patterns of KPC-producing or CTX-M-producing Enterobacteriaceae

scientific article published in March 2010

Antimicrobial susceptibility patterns of beta-hemolytic and viridans group streptococci: report from the SENTRY Antimicrobial Surveillance Program (1997-2000).

scientific article published in June 2002

Antimicrobial susceptibility patterns of community- and hospital-acquired methicillin-resistant Staphylococcus aureus from United States Hospitals: results from the AWARE Ceftaroline Surveillance Program (2012-2014).

scientific article published on 23 June 2016

Antimicrobial susceptibility patterns of unusual nonfermentative gram-negative bacilli isolated from Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2002).

scientific article

Antimicrobial susceptibility profile among beta-haemolytic Streptococcus spp. collected in the SENTRY Antimicrobial Surveillance Program--North America, 2001.

scientific article published in August 2003

Antimicrobial susceptibility profile of contemporary clinical strains of Stenotrophomonas maltophilia isolates: can moxifloxacin activity be predicted by levofloxacin MIC results?

scientific article published in February 2008

Antimicrobial susceptibility testing of Haemophilus influenzae, Branhamella catarrhalis, and Neisseria gonorrhoeae

scientific article published on December 1988

Antimicrobial susceptibility testing of clinical isolates of Bordetella pertussis from northern California: report from the SENTRY Antimicrobial Surveillance Program

scientific article

Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001).

scientific article

Antipseudomonal activity of piperacillin/tazobactam: more than a decade of experience from the SENTRY Antimicrobial Surveillance Program (1997-2007).

scientific article published in November 2009

Antistaphylococcal activity of ceforanide and cefonicid in the presence of human serum

scientific article

Apalcillin [PC-904]: spectrum of activity and beta-lactamase hydrolysis/inhibition.

scientific article

Application of Next-Generation Sequencing for Characterization of Surveillance and Clinical Trial Isolates: Analysis of the Distribution of β-lactamase Resistance Genes and Lineage Background in the United States

article

Application of an in vitro infection model and simulation for reevaluation of fluoroquinolone breakpoints for Salmonella enterica serotype typhi

scientific article

Application of the Etest to antimicrobial susceptibility testing of Legionella spp

scientific article published on 01 July 1994

Arbekacin activity against contemporary clinical bacteria isolated from patients hospitalized with pneumonia

scientific article published on 23 March 2015

Are Enterococcus faecalis strains with vat(E) in poultry a reservoir for human streptogramin resistance? vat(E) occurrence in human enterococcal bloodstream infections in North America (SENTRY Antimicrobial Surveillance Program, 2002).

scientific article published on January 2004

Assessment of BMS284756 MIC and 5-μg disk diffusion quality control studies tested against seven American type culture collection strains ⬇️

scientific article published on 01 December 2001

Assessment of Ceftazidime-Avibactam 30/20 μg Disk Content Versus MIC Results When Tested against Enterobacteriaceae and Pseudomonas aeruginosa

scientific article published on 21 March 2018

Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, Italy ⬇️

scientific article published on September 14, 2010

Assessment of pathogen frequency and resistance patterns among pediatric patient isolates: report from the 2004 SENTRY Antimicrobial Surveillance Program on 3 continents

scientific article

Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).

scientific article published in August 2004

Automation of polymerase chain reaction tests. Reduction of human errors leading to contamination

scientific article published in April 1995

Avibactam reverts the ceftazidime MIC90 of European Gram-negative bacterial clinical isolates to the epidemiological cut-off value

scientific article published on 6 December 2013

Avoparcin, a glycopeptide used in animal foods: Antimicrobial spectrum and potency tested against human isolates from the United States ⬇️

scientific article published on December 1, 1997

Azlocillin, a ureido penicillin active against Pseudomonas aeruginosa: interpretive zone standards and quality control parameters for tests with 75-mu g disks

scientific article published on July 1982

Aztreonam: antibacterial activity, beta-lactamase stability, and interpretive standards and quality control guidelines for disk-diffusion susceptibility tests.

scientific article published in November 1985

BAY 12-8039, a novel fluoroquinolone. Activity against important respiratory tract pathogens

scientific article published on 01 September 1998

BL-S786, a new parenteral cephalosporin. I. A collaborative in vitro susceptibility comparison to cephalothin against 5,762 clinical bacterial isolates.

scientific article

BMS284756 (formerly T-3811, a des-fluoroquinolone) potency and spectrum tested against over 10,000 bacterial bloodstream infection isolates from the SENTRY antimicrobial surveillance programme (2000).

scientific article

BMY-28100, a new oral cephalosporin: antimicrobial activity against nearly 7,000 recent clinical isolates, comparative potency with other oral agents, and activity against beta-lactamase producing isolates

scientific article published in January 1988

BMY28142, cefbuperazone (T-1982), and Sch 34343. Antimicrobial activity against 94 anaerobes compared to seven other antimicrobial agents

scientific article published on 01 May 1985

Background and Rationale for Revised Clinical and Laboratory Standards Institute Interpretive Criteria (Breakpoints) for Enterobacteriaceae andPseudomonas aeruginosa:I. Cephalosporins and Aztreonam ⬇️

scientific article published on January 18, 2013

Bacterial Pathogens Isolated from Patients with Bloodstream Infection: Frequencies of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997) ⬇️

scientific article published on July 1, 1998

Bacterial Pathogens Isolated from Patients with Bloodstream Infections in Latin America, 1997: Frequency of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program

scientific article published in June 1999

Bacterial Resistance: A Worldwide Problem ⬇️

scientific article published on 01 June 1998

Bacterial antibiotic resistance before and after clinical application in the United States.

scientific article

Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Grou

scientific article

Bactericidal activity and synergy studies of BAL9141, a novel pyrrolidinone-3-ylidenemethyl cephem, tested against streptococci, enterococci and methicillin-resistant staphylococci ⬇️

scientific article published on November 1, 2003

Bactericidal activity of BAL9141, a novel parenteral cephalosporin against contemporary Gram-positive and Gram-negative isolates

scientific article published in September 2004

Bactericidal activity of cefepime and ceftriaxone tested against Streptococcus pneumoniae

scientific article published on 01 December 2006

Bactericidal activity of cefotaxime, desacetylcefotaxime, rifampin, and various combinations tested at cerebrospinal fluid levels against penicillin-resistant Streptococcus pneumoniae ⬇️

scientific article published on May 1, 1995

Bactericidal activity of garenoxacin tested by kill-curve methodology against wild type and QRDR mutant strains of Streptococcus pneumoniae

scientific article published in November 2004

Baseline activity of telavancin against Gram-positive clinical isolates responsible for documented infections in U.S. hospitals (2011-2012) as determined by the revised susceptibility testing method

scientific article published on 27 October 2014

Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892.

scientific article published on October 1987

Binaphthyl-based dicationic peptoids with therapeutic potential.

scientific article published in January 2010

Biochemical characterization of the acquired metallo-beta-lactamase SPM-1 from Pseudomonas aeruginosa.

scientific article

Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998.

scientific article

Broth microdilution susceptibility testing of Campylobacter jejuni and the determination of quality control ranges for fourteen antimicrobial agents

scientific article

CANCER resistance surveillance program: initial results from hematology-oncology centers in North America. Chemotherapy Alliance for Neutropenics and the Control of Emerging Resistance

scientific article

CEM-101 activity against Gram-positive organisms

scientific article

CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria

scientific article

CI-934, a new difluoroquinolone: in vitro antibacterial activity and proposed disk diffusion test interpretive criteria

scientific article published on 01 March 1987

Can antimicrobial susceptibility testing results for ciprofloxacin or levofloxacin predict susceptibility to a newer fluoroquinolone, gatifloxacin?: Report from The SENTRY Antimicrobial Surveillance Program (1997-99).

scientific article published in April 2001

Canadian ofloxacin susceptibility study: a comparative study from 18 medical centers. Canadian Ofloxacin Study Group

scientific article published on 01 January 1995

Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).

scientific article

Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009

scientific article

Candida guilliermondii and other species of candida misidentified as Candida famata: assessment by vitek 2, DNA sequencing analysis, and matrix-assisted laser desorption ionization-time of flight mass spectrometry in two global antifungal surveillan

scientific article

Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18).

scientific article published on 29 December 2008

Carbapenem susceptibility discords among Acinetobacter isolates

scientific article published in January 2006

Carbapenem-resistant Serratia marcescens isolates producing Bush group 2f beta-lactamase (SME-1) in the United States: results from the MYSTIC Programme

scientific article published in February 2001

Carbapenem-resistant isolates of Klebsiella pneumoniae in China and detection of a conjugative plasmid (blaKPC-2 plus qnrB4) and a blaIMP-4 gene

scientific article published on 17 December 2007

Case report of Aurantimonas altamirensis bloodstream infection

scientific article published on 26 November 2008

Cefazolin as a class representative for oral cephalosporins and uncomplicated urinary tract infections caused by indicated Enterobacteriaceae

scientific article published on 3 October 2013

Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelines

scientific article

Cefdinir activity against contemporary North American isolates from community-acquired urinary tract infections

scientific article published in January 2005

Cefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infections

scientific article published on February 2007

Cefditoren activity against nearly 1000 non-fastidious bacterial isolates and the development of in vitro susceptibility test methods

scientific article

Cefditoren in vitro activity and spectrum: a review of international studies using reference methods ⬇️

scientific article published on September 1, 2001

Cefepime MIC as a predictor of the extended-spectrum beta-lactamase type in Klebsiella pneumoniae, Taiwan

scientific article published on May 2002

Cefixime disk susceptibility test criteria

scientific article published on October 1986

Cefixime: spectrum of antibacterial activity against 16,016 clinical isolates.

scientific article

Cefmenoxime (SCE-1365), a new Cephalosporin: In Vitro Activity, Comparison with Other Antimicrobial Agents, Beta-Lactamase Stability, and Disk Diffusion Testing with Tentative Interpretive Criteria ⬇️

scientific article published on December 1, 1981

Cefoperazone and cefoperazone-sulbactam susceptibility tests with anaerobic bacteria by the thioglycolate disk elution method

scientific article published on November 1985

Cefoperazone disk diffusion susceptibility test: confirmation of the tentative interpretive criteria, Pseudomonas aeruginosa cross-resistance, and determination of quality control performance limits ⬇️

scientific article published on May 1, 1982

Cefoperazone: evaluation of the in vitro activity and an analysis of the disk diffusion test

scientific article published on 01 January 1980

Cefoperazone: spectrum of antibacterial activity and disc diffusion testing

scientific article published on 01 January 1981

Cefotaxime: A Review of in Vitro Antimicrobial Properties and Spectrum of Activity ⬇️

scientific article published on September 1, 1982

Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing

scientific article published on November 1982

Cefotiam susceptibility testing criteria

scientific article published on December 1985

Cefpiramide: comparative in-vitro activity and beta-lactamase stability

scientific article published on 01 September 1985

Cefpirome (HR810) disk diffusion susceptibility tests: confirmation of interpretive criteria using cefotaxime and cefoperazone-resistant strains and effects of blood supplemented media

scientific article published on 01 April 1986

Cefquinome (HR 111V). In vitro evaluation of a broad-spectrum cephalosporin indicated for infections in animals

scientific article

Cefsulodin: antibacterial activity and tentative interpretive zone standards for the disk susceptibility test ⬇️

scientific article published on October 1, 1981

Ceftaroline Activity Against Multidrug-Resistant Streptococcus pneumoniae from U.S. Medical Centers (2014) and Molecular Characterization of a Single Ceftaroline Nonsusceptible Isolate

scientific article published on 5 December 2016

Ceftaroline Activity Tested Against Bacterial Isolates Causing Community-acquired Respiratory Tract Infections and Skin and Skin Structure Infections in Pediatric Patients From United States Hospitals: 2012-2014.

scientific article published on May 2017

Ceftaroline activity against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2009-2011).

scientific article

Ceftaroline activity against bacterial pathogens frequently isolated in U.S. medical centers: results from five years of the AWARE surveillance program

scientific article published on 2 February 2015

Ceftaroline activity against organisms isolated from respiratory tract infections in USA hospitals: results from the AWARE Program, 2009-2011.

scientific article published on 6 November 2013

Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study

scientific article published in November 2010

Ceftaroline activity tested against bacterial isolates from pediatric patients: results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011-2012).

scientific article published on August 2014

Ceftaroline activity tested against contemporary Latin American bacterial pathogens (2011).

scientific article

Ceftaroline activity tested against uncommonly isolated Gram-positive pathogens: report from the SENTRY Antimicrobial Surveillance Program (2008-2011).

scientific article published on 5 November 2013

Ceftaroline activity tested against viridans group streptococci from US hospitals

scientific article published on 3 November 2015

Ceftaroline potency among 9 US Census regions: report from the 2010 AWARE Program

scientific article published on 01 September 2012

Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests

scientific article published on September 1981

Ceftazidime-Avibactam Activity against Aerobic Gram Negative Organisms Isolated from Intra-Abdominal Infections in United States Hospitals, 2012-2014.

scientific article published on 22 April 2016

Ceftazidime-avibactam activity against multidrug-resistant Pseudomonas aeruginosa isolated in U.S. medical centers in 2012 and 2013.

scientific article published on 6 April 2015

Ceftazidime-avibactam activity tested against Enterobacteriaceae isolates from U.S. hospitals (2011 to 2013) and characterization of β-lactamase-producing strains

scientific article published on 6 April 2015

Ceftazidime-avibactam activity when tested against ceftazidime-nonsusceptible Citrobacter spp., Enterobacter spp., Serratia marcescens, and Pseudomonas aeruginosa from Unites States medical centers (2011-2014).

scientific article published on 17 June 2015

Ceftazidime-avibactam and comparator agents tested against urinary tract isolates from a global surveillance program (2011).

scientific article

Ceftazidime/avibactam activity tested against Gram-negative bacteria isolated from bloodstream, pneumonia, intra-abdominal and urinary tract infections in US medical centres (2012).

scientific article published on 20 February 2014

Ceftazidime/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated pneumonia

scientific article

Ceftibuten (7432-S, SCH 39720): comparative antimicrobial activity against 4735 clinical isolates, beta-lactamase stability and broth microdilution quality control guidelines

scientific article published on 01 December 1988

Ceftizoxime and cefoxitin susceptibility testing against anaerobic bacteria: comparison of results from three NCCLS methods and quality control recommendations for the reference agar dilution procedure

scientific article

Ceftizoxime interpretive criteria for in vitro susceptibility tests with Neisseria gonorrhoeae

scientific article published on September 1993

Ceftizoxime: collaborative multiphased in-vitro evaluation including tentative interpretive standards for disc susceptibility tests, -lactamase stability, and inhibition ⬇️

scientific article published on 01 November 1982

Ceftobiprole activity against over 60,000 clinical bacterial pathogens isolated in Europe, Turkey, and Israel from 2005 to 2010.

scientific article

Ceftolozane/tazobactam activity tested against Gram-negative bacterial isolates from hospitalised patients with pneumonia in US and European medical centres (2012)

scientific article published on 26 March 2014

Ceftolozane/tazobactam activity tested against aerobic Gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012).

scientific article published on 26 April 2014

Ceftriaxone: A summary of in vitro antibacterial qualities including recommendations for susceptibility tests with 30-μg disks ⬇️

scientific article published on December 1, 1983

Cefuroxime, an in vitro Comparison with Six Other Cephalosporins ⬇️

scientific article published on January 1, 1977

Cefuroxime, cefamandole, cefoxitin, and cephalothin in vitro susceptibility tests: reassessment of the "class representative" concept, confirmation of disk interpretive criteria, and proposed quality control guidelines

scientific article published on 01 August 1983

Changes in the Frequencies of β-Lactamase Genes among Enterobacteriaceae Isolates in U.S. Hospitals, 2012 to 2014: Activity of Ceftazidime-Avibactam Tested against β-Lactamase-Producing Isolates

scientific article published on 23 May 2016

Changing Antimicrobial Susceptibility Patterns among Streptococcus pneumoniae and Haemophilus influenzae from Brazil: Report from the SENTRY Antimicrobial Surveillance Program (1998–2004)

article

Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997.

scientific article published in September 1999

Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999.

scientific article published in May 2001

Characterization of Vancomycin-Heteroresistant Staphylococcus aureus from the Metropolitan Area of Detroit, Michigan, over a 22-Year Period (1986 to 2007).

scientific article published in December 2008

Characterization of an integron carrying blaIMP-1 and a new aminoglycoside resistance gene, aac(6')-31, and its dissemination among genetically unrelated clinical isolates in a Brazilian hospital

scientific article published on 30 April 2007

Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolid

scientific article published on 25 November 2009

Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY An

scientific article published on 10 March 2006

Characterization of heteroresistance to fluconazole among clinical isolates of Cryptococcus neoformans

scientific article

Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline

scientific article published on 7 March 2012

Characterization of methicillin-resistant Staphylococcus aureus strains recovered from a phase IV clinical trial for linezolid versus vancomycin for treatment of nosocomial pneumonia.

scientific article

Characterization of vancomycin-heteroresistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007).

scientific article published on 16 July 2008

Chloramphenicol susceptibility testing of Haemophilus influenzae

scientific article published on December 1987

Ciprofloxacin as broad-spectrum empiric therapy--are fluoroquinolones still viable monotherapeutic agents compared with beta-lactams: data from the MYSTIC Program (US)?

scientific article

Clarithromycin in vitro activity enhanced by its major metabolite, 14-hydroxyclarithromycin

scientific article published on 01 March 1992

Clindamycin resistance among erythromycin-resistant Streptococcus pneumoniae

scientific article published on 01 August 1996

Clinical evaluation of the Sensititre YeastOne colorimetric antifungal plate for antifungal susceptibility testing of the new triazoles voriconazole, posaconazole, and ravuconazole

scientific article published on October 2004

Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999.

scientific article published in May 2001

Clonal dissemination of Klebsiella pneumoniae carbapenemase KPC-3 in Long Beach, California

scientific article

Clonal dissemination of two clusters of Acinetobacter baumannii producing OXA-23 or OXA-58 in Rome, Italy

scientific article published on 27 April 2009

Clonal occurrences of multidrug-resistant Gram-negative bacilli: report from the Meropenem Yearly Susceptibility Test Information Collection Surveillance Program in the United States (2004).

scientific article published on 8 February 2006

Codetection of blaOXA-23-like gene (blaOXA-133) and blaOXA-58 in Acinetobacter radioresistens: report from the SENTRY antimicrobial surveillance program

scientific article published on 17 November 2008

Collaborative evaluation of the micro-media systems anaerobe susceptibility panel: comparisons with reference methods and test reproducibility

scientific article published on August 1982

Collaborative evaluation of the microbial profile system for quantitative antimicrobial susceptibility testing

scientific article published on March 1983

Colony morphology of Candida spp. as a guide to species identification

scientific article published on 01 September 1999

Combinations of Orally Administered β-Lactams to Maximize Spectrum and Activity against Drug-resistant Respiratory Tract Pathogens: I. Synergy Studies of Amoxicillin and Cefixime with Streptococcus pneumoniae ⬇️

scientific article published on June 1, 1998

Comment on: role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-β-lactamases

scientific article published on 20 October 2010

Commentary: revised susceptibility breakpoints: fear, loathing and good science

scientific article published in September 2013

Commercial broth microdilution panel validation and reproducibility trials for NVP PDF-713 (LBM 415), a novel inhibitor of bacterial peptide deformylase

scientific article published on 01 September 2004

Commercial broth microdilution panel validation and reproducibility trials for garenoxacin (BMS-284756), a novel desfluoroquinolone

scientific article published on August 2003

Comparative Antimicrobial Activity and Kill-Curve Investigations of Novel Ketolide Antimicrobial Agents (HMR 3004 and HMR 3647) Tested against Haemophilus influenzae and Moraxella catarrhalis Strains ⬇️

scientific article published on 01 June 1998

Comparative activities of cefepime and piperacillin/tazobactam tested against a global collection of Escherichia coli and Klebsiella spp. with an ESBL phenotype

scientific article published on 01 December 2006

Comparative activity and spectrum of broad-spectrum beta-lactams (cefepime, ceftazidime, ceftriaxone, piperacillin/tazobactam) tested against 12,295 staphylococci and streptococci: report from the SENTRY antimicrobial surveillance program (North Ame ⬇️

scientific article published on October 1, 2003

Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various beta-lactamase resistance mechanisms

scientific article published in May 2005

Comparative activity of garenoxacin (BMS 284756), a novel desfluoroquinolone, tested against 8,331 isolates from community-acquired respiratory tract infections: North American results from the SENTRY Antimicrobial Surveillance Program (1999–2001) ⬇️

scientific article published on April 1, 2003

Comparative activity of linezolid against respiratory tract infection isolates of Staphylococcus aureus: an 11-year report from the SENTRY Antimicrobial Surveillance Program ⬇️

scientific article published on April 14, 2011

Comparative activity of meropenem in US medical centers (2007): initiating the 2nd decade of MYSTIC program surveillance

scientific article published on 10 March 2008

Comparative activity of oral and parenteral cephalosporins tested against multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1997-2003).

scientific article published in February 2005

Comparative activity of twelve beta-lactam drugs tested against penicillin-resistant Streptococcus pneumoniae from five medical centers: effects of serum protein and capsular material on potency and spectrum as measured by reference tests

scientific article published on 01 July 1996

Comparative antimicrobial activity of ABT-773, a novel ketolide, tested against drug-resistant Gram-positive cocci and Haemophilus influenzae

scientific article published in June 2001

Comparative antimicrobial activity of aminothiazolyl methoxyimino cephalosporins against anaerobic bacteria, including 100 cefoxitin-resistant isolates

scientific article published on November 1987

Comparative antimicrobial activity of gatifloxacin tested against Campylobacter jejuni including fluoroquinolone-resistant clinical isolates

scientific article published on June 1999

Comparative antimicrobial activity of gatifloxacin tested against Streptococcus spp. including quality control guidelines and etest method validation. Quality Control Study Group

scientific article published in June 1999

Comparative antimicrobial activity of piperacillin-tazobactam tested against more than 5000 recent clinical isolates from five medical centers a reevaluation after five years ⬇️

scientific article published on March 1, 1995

Comparative antimicrobial activity of trovafloxacin tested against 3049 Streptococcus pneumoniae isolates from the 1997-1998 respiratory infection season

scientific article published on 01 October 1998

Comparative antimicrobial characterization of LBM415 (NVP PDF-713), a new peptide deformylase inhibitor of clinical importance

scientific article

Comparative antimicrobial potency of meropenem tested against Gram-negative bacilli: report from the MYSTIC surveillance program in the United States (2004).

scientific article published in October 2005

Comparative antimicrobial spectrum and activity of BMS284756 (T-3811, a desfluoroquinolone) tested against 656 Enterobacteriaceae, including preliminary in vitro susceptibility test comparisons and development

scientific article published in August 2001

Comparative antimicrobial spectrum and activity of BMS284756 (T-3811; a desfluoroquinolone) tested against an international collection of staphylococci and enterococci, including in vitro test development and intermethod comparisons

scientific article published in February 2002

Comparative antimicrobial spectrum and activity of the desfluoroquinolone BMS284756 (T-3811) tested against non-fermentative Gram-negative bacilli

scientific article published in June 2002

Comparative antistreptococcal activity of two newer fluoroquinolones, levofloxacin and sparfloxacin ⬇️

scientific article published on November 1, 1997

Comparative assessment of Etest for testing susceptibilities of Neisseria gonorrhoeae to penicillin, tetracycline, ceftriaxone, cefotaxime, and ciprofloxacin: investigation using 510(k) review criteria, recommended by the Food and Drug Administratio

scientific article published on December 1996

Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: results from an international surveillance study ⬇️

scientific article published on April 1, 2011

Comparative evaluation of etest for susceptibility testing Neisseria meningitidis with eight antimicrobial agents. An investigation using U.S. Food and Drug Administration regulatory criteria

scientific article published on 01 March 1997

Comparative in vitro activity of gatifloxacin against Stenotrophomonas maltophilia and Burkholderia species isolates including evaluation of disk diffusion and E test methods

scientific article

Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA ⬇️

scientific article published on November 1, 1997

Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results

scientific article

Comparative potencies of contemporary generic vancomycin lot: in vitro assay results from nine products and a reference reagent-grade sample

scientific article published on 21 February 2013

Comparative spectrum and activity of NVP-PDF386 (VRC4887), a new peptide deformylase inhibitor

scientific article published on 01 January 2003

Comparison of 2002-2006 OPTAMA programs for US hospitals: focus on gram-negative resistance

scientific article published on 3 February 2009

Comparison of 30-min and 3-h infusion regimens for imipenem/cilastatin and for meropenem evaluated by Monte Carlo simulation ⬇️

scientific article published on September 18, 2010

Comparison of BD Max StaphSR and BD Max MRSAXT for Screening of Staphylococcus aureus Clinical Isolates Collected from Hospitals in the United States

scientific article published on 23 March 2016

Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 systemically active antifungal agents when tested against Candida spp.

scientific article published on 17 March 2014

Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species.

scientific article published on 24 March 2010

Comparison of Streptococcus pneumoniae and Haemophilus influenzae susceptibilities from community-acquired respiratory tract infections and hospitalized patients with pneumonia: five-year results for the SENTRY Antimicrobial Surveillance Program

scientific article published in August 2003

Comparison of amino acid decarboxylase and dihydrolase results by Moeller, rapid, and replicator plate methods

scientific article published on January 1976

Comparison of cefadroxil and cephalothin disk susceptibility test results

scientific article published on July 1989

Comparison of censored regression and standard regression analyses for modeling relationships between antimicrobial susceptibility and patient- and institution-specific variables

scientific article published in January 2006

Comparison of dalbavancin MIC values determined by Etest (AB BIODISK) and reference dilution methods using gram-positive organisms

scientific article

Comparison of identification systems for Staphylococcus epidermidis and other coagulase-negative Staphylococcus species

scientific article published on 01 March 1994

Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin

scientific article published on August 1980

Comparison of oral immediate-release (IR) and extended-release (ER) metronidazole bactericidal activity against Bacteroides spp. using an in vitro model of infection

scientific article published on 01 May 2000

Comparison of the Vitek Gram-Positive Susceptibility 106 card and the MRSA-screen latex agglutination test for determining oxacillin resistance in clinical bloodstream isolates of Staphylococcus aureus

scientific article

Comparison of the Vitek gram-positive susceptibility 106 card, the MRSA-Screen latex agglutination test, and mecA analysis for detecting oxacillin resistance in a geographically diverse collection of clinical isolates of coagulase-negative staphyloc

scientific article

Comparison of the activity of two broad-spectrum cephalosporins tested against 2,299 strains of Pseudomonas aeruginosa isolated at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998

scientific article published on 01 February 2000

Comparison of the antibacterial spectra of cephalexin and cefaclor with those of cephalothin and newer cephalosporins: reevaluation of the class representative concept of susceptibility testing.

scientific article published on June 1983

Comparison of the probability of target attainment between ceftriaxone and cefepime in the cerebrospinal fluid and serum against Streptococcus pneumoniae

scientific article published on 23 May 2007

Comparison of two commercial systems (Vitek and MicroScan-WalkAway) for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients

scientific article

Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).

scientific article

Comparisons of the in vitro susceptibility testing results for garenoxacin using six different national methods: report from the garenoxacin international bridging study

scientific article

Complete Sequence of p07-406, a 24,179-base-pair plasmid harboring the blaVIM-7 metallo-beta-lactamase gene in a Pseudomonas aeruginosa isolate from the United States

scientific article published on 30 June 2008

Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity?

scientific article published on 27 September 2007

Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibiotics

scientific article published on November 1980

Comprehensive assessment of tigecycline activity tested against a worldwide collection of Acinetobacter spp. (2005–2009) ⬇️

scientific article published on November 1, 2010

Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp.

scientific article published in May 2005

Comprehensive update of dalbavancin activity when tested against uncommonly isolated streptococci, Corynebacterium spp., Listeria monocytogenes, and Micrococcus spp. (1357 strains)

scientific article published on 13 February 2013

Confirmation of extended-spectrum beta-lactamase-producing Serratia marcescens: preliminary report from Taiwan

scientific article published in April 2003

Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09)

scientific article published on 29 June 2011

Contemporary activity of meropenem and comparator broad-spectrum agents: MYSTIC program report from the United States component (2005).

scientific article

Contemporary antimicrobial activity of triple antibiotic ointment: a multiphased study of recent clinical isolates in the United States and Australia

scientific article published in January 2006

Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines

scientific article

Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).

scientific article

Contemporary diversity of β-lactamases among Enterobacteriaceae in the nine U.S. census regions and ceftazidime-avibactam activity tested against isolates producing the most prevalent β-lactamase groups

scientific article published on 18 November 2013

Contemporary evaluation of the in vitro activity and spectrum of cefdinir compared with other orally administered antimicrobials tested against common respiratory tract pathogens (2000-2002) ⬇️

scientific article published on November 1, 2003

Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18569 strains non-fermentative Gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997-2001).

scientific article

Contemporary in vitro synergy rates for aztreonam combined with newer fluoroquinolones and β-lactams tested against gram-negative bacilli ⬇️

scientific article published on November 1, 2003

Contemporary potencies of minocycline and tetracycline HCL tested against Gram-positive pathogens: SENTRY Program results using CLSI and EUCAST breakpoint criteria ⬇️

scientific article published on April 1, 2013

Contemporary prevalence of BRO beta-lactamases in Moraxella catarrhalis: report from the SENTRY antimicrobial surveillance program (North America, 1997 to 2004)

scientific article

Contemporary re-evaluation of the activity and spectrum of grepafloxacin tested against isolates in the United States

scientific article published in September 2003

Contemporary tetracycline susceptibility testing: doxycycline MIC methods and interpretive criteria (CLSI and EUCAST) performance when testing Gram-positive pathogens ⬇️

scientific article published on March 13, 2013

Criteria for disk susceptibility tests and quality control guidelines for the cefoperazone-sulbactam combination

scientific article published on January 1988

Critical appraisal of E test for the detection of fluoroquinolone resistance

scientific article published on 01 July 1996

Critical evaluation of the Vitek GNS F6 card results compared to standardized, reference susceptibility test methods ⬇️

scientific article published on 01 May 1997

Cross susceptibility and absence of cross resistance to cefotetan and cefoxitin.

scientific article published on August 1987

Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations

scientific article published on June 1984

Cross-resistance analysis for DU-6859a, a new fluoroquinolone, compared to six structurally similar compounds (ciprofloxacin, clinafloxacin, fleroxacin, levofloxacin, ofloxacin, and sparfloxacin).

scientific article

Cross-resistance analysis for clinafloxacin compared with ciprofloxacin, fleroxacin, ofloxacin, and sparfloxacin using a predictor panel of ciprofloxacin-resistant bacteria

scientific article published on 01 August 1995

Current susceptibilities of staphylococci to glycopeptides determined as part of an international resistance surveillance programme. Sentry Antimicrobial Surveillance Program ⬇️

scientific article published on July 1, 1998

Dalbavancin Activity When Tested against Streptococcus pneumoniae Isolated in Medical Centers on Six Continents (2011 to 2014).

scientific article published on 21 March 2016

Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens

scientific article published in December 2005

Daptomycin activity against uncommonly isolated streptococcal and other gram-positive species groups

scientific article published on 30 September 2013

Daptomycin activity and spectrum: a worldwide sample of 6737 clinical Gram-positive organisms

scientific article published on 25 February 2004

Daptomycin activity tested against 164457 bacterial isolates from hospitalised patients: summary of 8 years of a Worldwide Surveillance Programme (2005-2012).

scientific article published on 17 February 2014

Daptomycin activity tested against linezolid-nonsusceptible gram-positive clinical isolates

scientific article published in December 2009

Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).

scientific article published on 18 April 2007

Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin

scientific article

Daptomycin in vitro activity tested against Gram-positive strains collected from European and Latin American medical centers in 2003.

scientific article published in October 2005

Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovis

scientific article

Declining antimicrobial susceptibility of Streptococcus pneumoniae in the United States: report from the SENTRY Antimicrobial Surveillance Program (1998–2009) ⬇️

scientific article published on 01 November 2010

Decreased ceftriaxone susceptibility in emerging (35B and 6C) and persisting (19A) Streptococcus pneumoniae serotypes in the United States, 2011-2012: ceftaroline remains active in vitro among β-lactam agents

scientific article published on 27 May 2014

Definitions and Epidemiology of Candida Species not Susceptible to Echinocandins

scholarly article by Michael A. Pfaller et al published 5 April 2011 in Current fungal infection reports

Delafloxacin In Vitro Broth Microdilution and Disk Diffusion Antimicrobial Susceptibility Testing Guidelines: Susceptibility Breakpoint Criteria and Quality Control Ranges for an Expanded-Spectrum Anionic Fluoroquinolone

scientific article published on 26 July 2018

Delayed resistance selection for doripenem when passaging Pseudomonas aeruginosa isolates with doripenem plus an aminoglycoside

scientific article published on 24 May 2006

Desacetylcefotaxime--another broad spectrum cephalosporin?

scientific article

Detection of NDM-1-producing Enterobacteriaceae in Romania: report of the SENTRY Antimicrobial Surveillance Program

scientific article

Detection of a New cfr-Like Gene, cfr(B), in Enterococcus faecium Isolates Recovered from Human Specimens in the United States as Part of the SENTRY Antimicrobial Surveillance Program

scientific article

Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen.

scientific article published on August 1996

Detection of mcr-1 among Escherichia coli Clinical Isolates Collected Worldwide as Part of the SENTRY Antimicrobial Surveillance Program in 2014 and 2015.

scientific article published on 11 July 2016

Detection of methyltransferases conferring high-level resistance to aminoglycosides in enterobacteriaceae from Europe, North America, and Latin America

scientific article published on 17 March 2008

Detection of staphylococcal resistance to penicillinase-resistant penicillins. A comparison of two widely used disk diffusion methods

scientific article

Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection

scientific article published on 12 July 2010

Determination of Disk Diffusion and MIC Quality Control Guidelines for High Dose Cefepime-Tazobactam (WCK 4282), a Novel Antibacterial Combination Consisting of a β-Lactamase Inhibitor and a Fourth-Generation Cephalosporin

scientific article published on 9 August 2017

Determination of Disk Diffusion and MIC Quality Control Guidelines for JNJ-Q2, a Novel Quinolone ⬇️

scientific article published on June 8, 2011

Determination of Disk Diffusion and MIC Quality Control Guidelines for Solithromycin, a Novel Fluoroketolide Antibacterial, against Neisseria gonorrhoeae

scientific article published on 16 September 2015

Determination of MIC quality control ranges for ABT-733, a novel ketolide antimicrobial agent. Quality Control Study Group

scientific article published on June 2000

Determination of disk diffusion and MIC quality control guidelines for GSK2140944, a novel bacterial type II topoisomerase inhibitor antimicrobial agent

scientific article published on 23 April 2014

Determination of disk diffusion and MIC quality control guidelines for GSK2251052: a novel boron-containing antibacterial

scientific article published on 23 February 2013

Determination of disk diffusion and MIC quality control parameters for AZD2563, a novel long-acting oxazolidinone

scientific article published in January 2003

Determination of disk diffusion and MIC quality control ranges for GSK1322322, a novel peptide deformylase inhibitor

scientific article published on 14 September 2011

Determination of epidemic clonality among multidrug-resistant strains of Acinetobacter spp. and Pseudomonas aeruginosa in the MYSTIC Programme (USA, 1999-2003).

scientific article published in July 2004

Determination of the antimicrobial activity of 29 clinically important compounds tested against fastidious HACEK group organisms

scientific article published in May 1999

Development of a disk diffusion method for testing Moraxella catarrhalis susceptibility using clinical and laboratory standards institute methods: a SENTRY antimicrobial surveillance program report

scientific article published on 20 May 2009

Development of a standardized susceptibility test for campylobacter with quality-control ranges for ciprofloxacin, doxycycline, erythromycin, gentamicin, and meropenem.

scientific article published in January 2004

Development of anidulafungin for disk diffusion susceptibility testing against Candida spp.

scientific article published on 26 March 2007

Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapy

scientific article published on 01 August 2006

Development of gemifloxacin in vitro susceptibility test methods for gonococci including quality control guidelines. The Quality Control Study Group

scientific article published on 01 July 2000

Development of in vitro susceptibility testing methods for gemifloxacin (formerly LB20304a or SB-265805), an investigational fluoronaphthyridone

scientific article published on 01 November 1999

Development, characterization, and initial evaluations of S1. A new chromogenic cephalosporin for beta-lactamase detection

scientific article published in January 1995

Differences in potency and categorical agreement between colistin and polymyxin B when testing 15,377 clinical strains collected worldwide

scientific article published on 28 August 2015

Dilution Factor of Quantitative Bacterial Cultures Obtained by Bronchoalveolar Lavage in Patients with Ventilator-Associated Bacterial Pneumonia

scientific article published on 16 October 2017

Disk agar diffusion susceptibility testing with 30-micrograms ceftazidime disks: confirmation of interpretive breakpoints and quality control guidelines ⬇️

scientific article published on July 1, 1983

Disk diffusion and MIC quality control ranges for BC-3205 and BC-3781, two novel pleuromutilin antibiotics

scientific article published on 18 July 2012

Disk diffusion and disk elution tests with A-56268 and erythromycin

scientific article

Disk diffusion quality control guidelines for Haemophilus susceptibility tests using cefdinir, CI-960, fleroxacin, temafloxacin, and trospectomycin ⬇️

scientific article published on March 1, 1992

Disk diffusion quality control guidelines for NVP-PDF 713: a novel peptide deformylase inhibitor

scientific article published in January 2004

Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporin

scientific article

Disk diffusion susceptibility testing for LY163892 (KT-3777), a new orally administered 1-carbacephem

scientific article published on April 1988

Disk diffusion susceptibility testing of ticarcillin plus clavulanic acid

scientific article published on April 1984

Disk diffusion susceptibility testing of two macrolide antimicrobial agents: revised interpretive criteria for erythromycin and preliminary guidelines for roxithromycin (RU 965).

scientific article published on August 1986

Disk diffusion test interpretive criteria and quality control recommendations for testing linezolid (U-100766) and eperezolid (U-100592) with commercially prepared reagents ⬇️

scientific article published on December 1, 1997

Disk diffusion testing, quality control guidelines, and antimicrobial spectrum of HR810, a fourth-generation cephalosporin, in clinical microbiology laboratories

scientific article published on September 1984

Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program

scientific article published in January 2005

Dissemination and genetic context analysis of bla(VIM-6) among Pseudomonas aeruginosa isolates in Asian-Pacific Nations

scientific article

Dissemination of a pSCFS3-like cfr-carrying plasmid in Staphylococcus aureus and Staphylococcus epidermidis clinical isolates recovered from hospitals in Ohio

scientific article published on 09 April 2013

Distribution of fsr among Enterococcus faecalis isolates from the SENTRY antimicrobial surveillance program

scientific article published on August 2003

Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations

scientific article

Doxycycline use for community-acquired pneumonia: contemporary in vitro spectrum of activity against Streptococcus pneumoniae (1999-2002)

scientific article published on 01 June 2004

E test as susceptibility test and epidemiologic tool for evaluation of Neisseria meningitidis isolates

scientific article published on December 1993

Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007.

scientific article published on 28 December 2010

Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY

scientific article published on 01 January 2011

Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geogr

scientific article published on 29 May 2013

Educational antimicrobial susceptibility testing as a critical component of microbiology laboratory proficiency programs: American Proficiency Institute results for 2007-2011.

scientific article published on 6 March 2013

Effect of beta-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic beta-lactamase producing bacteria

scientific article published on 01 September 1987

Effect of the β-Lactamase Inhibitor Vaborbactam Combined with Meropenem against Serine Carbapenemase-Producing Enterobacteriaceae

scientific article published on 05 July 2016

Effects of breakpoint changes on carbapenem susceptibility rates of Enterobacteriaceae: Results from the SENTRY Antimicrobial Surveillance Program, United States, 2008 to 2012

scientific article published on September 2014

Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus

scientific article published on December 1994

Eight-year (2002-2009) summary of the linezolid (Zyvox® Annual Appraisal of Potency and Spectrum; ZAAPS) program in European countries

scientific article published on April 2011

Emergence and clonal dissemination of OXA-24- and OXA-58-producing Acinetobacter baumannii strains in Houston, Texas: report from the SENTRY Antimicrobial Surveillance Program

scientific article published on September 2008

Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial Surveillance Program (2001-2004).

scientific article published on 19 January 2006

Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program

scientific article published on 27 October 2008

Emergence of a plasmid mediated bla (VIM-1) in Citrobacter koseri: report from the SENTRY Antimicrobial Surveillance Program (Italy).

scientific article

Emergence of an IMP-like metallo-enzyme in an Acinetobacter baumannii clinical strain from a Brazilian teaching hospital

scientific article published on 01 January 2003

Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003)

scientific article published on 20 March 2006

Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: report from the MYSTIC Program (1999-2005).

scientific article

Emergence of the extended-spectrum beta-lactamase GES-1 in a Pseudomonas aeruginosa strain from Brazil: report from the SENTRY antimicrobial surveillance program

scientific article published in June 2004

Emergence of two Klebsiella pneumoniae isolates harboring plasmid-mediated CTX-M-15 beta-lactamase in Taiwan

scientific article published in January 2004

Emerging elevated mupirocin resistance rates among staphylococcal isolates in the SENTRY Antimicrobial Surveillance Program (2000): correlations of results from disk diffusion, Etest and reference dilution methods

scientific article

Emerging epidemic of metallo-beta-lactamase-mediated resistances

scientific article published in February 2005

Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (199

scientific article published in May 2001

Emerging metallo-beta-lactamase-mediated resistances: a summary report from the worldwide SENTRY antimicrobial surveillance program.

scientific article

Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States. Enterococcus Study Group

scientific article published on February 1995

Emerging multiply resistant enterococci among clinical isolates. II. Validation of the etest to recognize glycopeptide-resistant strains

scientific article published in February 1995

Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: the role of streptogramins and other newer compounds.

scientific article

Epidemiologic typing of multiply drug-resistant Pseudomonas aeruginosa isolated from an outbreak in an intensive care unit

scientific article

Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries

scientific article published on 05 March 2014

Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America).

scientific article

Erratum for Drusano et al., "Dilution Factor of Quantitative Bacterial Cultures Obtained by Bronchoalveolar Lavage in Patients with Ventilator-Associated Bacterial Pneumonia".

scientific article published on 27 March 2018

Escherichia coli resistance to quinolones at a comprehensive cancer center

scientific article published on 15 May 2010

Etest for routine clinical antimicrobial susceptibility testing of rapid-growing mycobacteria isolates

scientific article

Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centers

scientific article

Evaluation of Etest Method for Determining Caspofungin (MK-0991) Susceptibilities of 726 Clinical Isolates of Candida Species ⬇️

scientific article published on December 1, 2001

Evaluation of Etest Method for Determining Posaconazole MICs for 314 Clinical Isolates of Candida Species ⬇️

scientific article published on November 1, 2001

Evaluation of PPI-0903M (T91825), a novel cephalosporin: bactericidal activity, effects of modifying in vitro testing parameters and optimization of disc diffusion tests

scientific article published on 20 October 2005

Evaluation of S1 chromogenic cephalosporin beta-lactamase disk assay tested against gram-positive anaerobes, coagulase-negative staphylococci, Prevotella spp. and Enterococcus spp

scientific article published on 01 August 1995

Evaluation of Vancomycin and Daptomycin Potency Trends (MIC Creep) against Methicillin-Resistant Staphylococcus aureus Isolates Collected in Nine U.S. Medical Centers from 2002 to 2006.

scientific article published in March 2010

Evaluation of Vitek and API 20S for species identification of enterococci

scientific article published on 01 August 1995

Evaluation of a proprietary broth medium for microdilution susceptibility testing of nutritionally fastidious bacteria

scientific article

Evaluation of alternative disk diffusion methods for detecting mecA-mediated oxacillin resistance in an international collection of staphylococci: validation report from the SENTRY Antimicrobial Surveillance Program

scientific article published in January 2005

Evaluation of antimicrobial sensitivity of 87 clinical isolates of vancomycin-resistant enterococci

scientific article

Evaluation of clonality and carbapenem resistance mechanisms among Acinetobacter baumannii-Acinetobacter calcoaceticus complex and Enterobacteriaceae isolates collected in European and Mediterranean countries and detection of two novel β-lactamases,

scientific article

Evaluation of dalbavancin in combination with nine antimicrobial agents to detect enhanced or antagonistic interactions

scientific article published on 12 May 2006

Evaluation of daptomycin, telavancin, teicoplanin, and vancomycin activity in the presence of albumin or serum

scientific article

Evaluation of disk susceptibility testing of cefotaxime/desacetylcefotaxime

scientific article

Evaluation of gemifloxacin (SB-265805, LB20304a): in vitro activity against over 6000 gram-positive pathogens from diverse geographic areas

scientific article published on 01 August 2000

Evaluation of in vitro antibacterial activity of enoxacin: comparison with other orally absorbed antimicrobial agents, proposed disk diffusion test interpretive criteria, and quality control limits

scientific article

Evaluation of in vitro methods for testing ceftriaxone against anaerobic bacteria, including quality control guidelines.

scientific article published on April 1988

Evaluation of in vitro susceptibility testing criteria for gemifloxacin when tested against Haemophilus influenzae strains with reduced susceptibility to ciprofloxacin and ofloxacin

scientific article published in August 2002

Evaluation of interhospital spread of methicillin-resistant Staphylococcus aureus in Sao Paulo, Brazil, using pulsed-field gel electrophoresis of chromosomal DNA.

scientific article

Evaluation of low-dose, extended-interval clindamycin regimens against Staphylococcus aureus and Streptococcus pneumoniae using a dynamic in vitro model of infection

scientific article

Evaluation of quinolone resistance-determining region mutations and efflux pump expression in Neisseria meningitidis resistant to fluoroquinolones

scientific article published on 01 March 2012

Evaluation of quinupristin/dalfopristin (Synercid) and RPR 106972 stability in susceptibility testing media

scientific article published on 01 August 2000

Evaluation of reference dilution test methods for antimicrobial susceptibility testing of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis

scientific article

Evaluation of teicoplanin and vancomycin disk susceptibility tests

scientific article published on January 1986

Evaluation of the Etest for antimicrobial spectrum and potency determinations of anaerobes associated with bacterial vaginosis and peritonitis

scientific article published on 01 December 1994

Evaluation of the Etest for determinations of antimicrobial spectrum and potency against anaerobes associated with bacterial vaginosis and peritonitis

scientific article published in June 1995

Evaluation of the Etest method for determining voriconazole susceptibilities of 312 clinical isolates of Candida species by using three different agar media

scientific article

Evaluation of the MICUR system for quantitative antimicrobial susceptibility testing: a multiphasic comparison with reference methods

scientific article published on July 1982

Evaluation of the Sceptor microdilution antibiotic susceptibility testing system: a collaborative investigation

scientific article published on January 1981

Evaluation of the Sensititre system for quantitative antimicrobial drug susceptibility testing: a collaborative study

scientific article published on March 1980

Evaluation of the Vitek system to accurately test the susceptibility of Pseudomonas aeruginosa clinical isolates against cefepime

scientific article published on 01 October 1998

Evaluation of the activity of fusidic acid tested against contemporary Gram-positive clinical isolates from the USA and Canada

scientific article published on 29 December 2009

Evaluation of the cefonicid disk test criteria, including disk quality control guidelines

scientific article published on February 1983

Evaluation of the contemporary occurrence rates of metallo-beta-lactamases in multidrug-resistant Gram-negative bacilli in Japan: report from the SENTRY Antimicrobial Surveillance Program (1998-2002).

scientific article

Evaluation of the discriminatory powers of the Dienes test and ribotyping as typing methods for Proteus mirabilis

scientific article

Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin

scientific article published on May 1985

Evaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002-2005)

scientific article published on 19 January 2007

Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against recent clinical isolates from India: a survey of ten medical center laboratories

scientific article published in December 2002

Evaluation of the in vitro antimicrobial activity of cefepime compared to other broad-spectrum beta-lactams tested against recent clinical isolates from 10 Chinese hospitals. Chinese Antimicrobial Resistance Study Group

scientific article

Evaluation of the in-vitro activity of furopenem (SY5555 or SUN5555) against respiratory tract pathogens and β-lactamase producing bacteria ⬇️

scientific article published on 01 April 1995

Evaluation of the sensititre microdilution antibiotic susceptibility system against recent clinical isolates: three-laboratory collaborative study.

scientific article published on April 1980

Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006.

scientific article published on 27 July 2009

Evaluation of vancomycin susceptibility testing for methicillin-resistant Staphylococcus aureus: comparison of Etest and three automated testing methods

scientific article published on 17 April 2013

Evaluations of the Etest for antimicrobial susceptibility testing of Legionella pneumophila, including validation of the imipenem and sparfloxacin strips

scientific article published on 01 November 1994

Evolution and dissemination of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: epidemiology and molecular report from the SENTRY Antimicrobial Surveillance Program (1997-2003).

scientific article published in January 2005

Evolution of Ceftaroline-Resistant Mrsa in a Child with Cystic Fibrosis Following Repeated Antibiotic Exposure

scientific article published on 18 April 2016

Evolution of an integron carrying blaVIM-2 in Eastern Europe: report from the SENTRY Antimicrobial Surveillance Program.

scientific article published on 12 June 2003

Evolving trends in Streptococcus pneumoniae resistance: implications for therapy of community-acquired bacterial pneumonia

scientific article published on 16 June 2010

Expanded studies of piperacillin/tazobactam formulations: variations among branded product lots and assessment of 46 generic lots

scientific article published in November 2009

Expansion of clonal complex 258 KPC-2-producing Klebsiella pneumoniae in Latin American hospitals: report of the SENTRY Antimicrobial Surveillance Program

scientific article published on March 2012

Factors influencing broth microdilution antimicrobial susceptibility test results for dalbavancin, a new glycopeptide agent

scientific article

False resistance results using 5 micrograms cefixime disks to test Haemophilus influenzae

scientific article

False resistance to metronidazole by E-test among anaerobic bacteria investigations of contributing test conditions and medium quality

scientific article published on 01 February 1996

First description of Klebsiella pneumoniae harboring CTX-M beta-lactamases (CTX-M-14 and CTX-M-3) in Taiwan

scientific article

First descriptions of blaKPC in Raoultella spp. (R. planticola and R. ornithinolytica): report from the SENTRY Antimicrobial Surveillance Program

scientific article published on 07 October 2009

First isolation of bla(VIM-2) in Latin America: report from the SENTRY Antimicrobial Surveillance Program

scientific article published in April 2004

First report of Staphylococcal clinical isolates in Mexico with linezolid resistance caused by cfr: evidence of in vivo cfr mobilization

scientific article published on 2 June 2010

First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States

scientific article published on 7 April 2008

Five-year analysis of Haemophilus influenzae isolates with reduced susceptibility to fluoroquinolones: prevalence results from the SENTRY antimicrobial surveillance program ⬇️

scientific article published on May 1, 2003

Fixed-ratio combination testing of an echinocandin, anidulafungin, and an azole, voriconazole, against 1,467 Candida species isolates

scientific article published on 14 June 2010

Fluoroquinolone-resistant Haemophilus influenzae: frequency of occurrence and analysis of confirmed strains in the SENTRY antimicrobial surveillance program (North and Latin America).

scientific article

Fluoroquinolone-resistant Moraxella catarrhalis in a patient with pneumonia: report from the SENTRY Antimicrobial Surveillance Program (1998)

scientific article published on 01 October 1998

Fluoroquinolone-resistant Streptococcus pneumoniae, an emerging but unrecognized public health concern: is it time to resight the goalposts?

scientific article published on 01 November 2004

Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers

scientific article

Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata

scientific article published on 25 January 2012

Frequency of fks mutations among Candida glabrata isolates from a 10-year global collection of bloodstream infection isolates

scientific article published on 14 October 2013

Frequency of occurrence and antimicrobial susceptibility of Gram-negative bacteremia isolates in patients with urinary tract infection: results from United States and European hospitals (2009-2011).

scientific article

Frequency of occurrence and daptomycin susceptibility rates of Gram-positive organisms causing bloodstream infections in cancer patients

scientific article published in October 2008

Fusidic acid resistance rates and prevalence of resistance mechanisms among Staphylococcus spp. isolated in North America and Australia, 2007-2008.

scientific article published on 21 June 2010

GAR-936 (9-t-butylglycylamido-minocycline) susceptibility test development for streptococci, Haemophilus influenzae and Neisseria gonorrhoeae: preliminary guidelines and interpretive criteria

scientific article published in July 2001

Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae

scientific article published on 03 April 2007

Gatifloxacin (AM-1155, CG 5501) susceptibility testing interpretive criteria and quality control guidelines for dilution and disk (5-microgram) diffusion methods. The Quality Control Study Group

scientific article

Gatifloxacin phase IV surveillance trial (TeqCES study) utilizing 5000 primary care physician practices: report of pathogens isolated and susceptibility patterns in community-acquired respiratory tract infections

scientific article published in September 2002

Gatifloxacin used for therapy of outpatient community-acquired pneumonia caused by Streptococcus pneumoniae

scientific article published in September 2002

Genetic characterization of a novel metallo-beta-lactamase gene, blaIMP-13, harboured by a novel Tn5051-type transposon disseminating carbapenemase genes in Europe: report from the SENTRY worldwide antimicrobial surveillance programme.

scientific article published in September 2003

Genetic relatedness of multidrug-resistant, methicillin (oxacillin)-resistant Staphylococcus aureus bloodstream isolates from SENTRY Antimicrobial Resistance Surveillance Centers worldwide, 1998.

scientific article published in January 2000

Genotypic Characterization of Methicillin-Resistant Staphylococcus aureus Recovered at Baseline from Phase 3 Pneumonia Clinical Trials for Ceftobiprole

scientific article published on 31 July 2015

Genotypic characterization of carbapenem-nonsusceptible Acinetobacter spp. isolated in Latin America

scientific article published in January 2004

Gentamicin and amikacin disk susceptibility tests with Pseudomonas aeruginosa: definition of minimal inhibitory concentration correlates for susceptible and resistant categories.

scientific article published on May 1981

Gentamicin, tobramycin, and sisomicin disc susceptibility tests. Revised zone standards for interpretation

scientific article published on 01 April 1981

Geographic Variations in Species Distribution and Echinocandin and Azole Antifungal Resistance Rates among Candida Bloodstream Infection Isolates: Report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009) ⬇️

scientific article published on November 10, 2010

Geographic and Temporal Patterns of Antimicrobial Resistance in Over 20 Years From the SENTRY Antimicrobial Surveillance Program, 1997-2016

scientific article published on 15 March 2019

Geographic variations and trends in antimicrobial resistance among Enterococcus faecalis and Enterococcus faecium in the SENTRY Antimicrobial Surveillance Program (1997–2000) ⬇️

scientific article published on May 1, 2003

Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000).

scientific article published in July 2002

Geographic variations in garenoxacin (BMS284756) activity tested against pathogens associated with skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (2000).

scientific article published in August 2002

Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004).

scientific article

Global emergence of trimethoprim/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes

scientific article published on April 2007

Global patterns of susceptibility for 21 commonly utilized antimicrobial agents tested against 48,440 Enterobacteriaceae in the SENTRY Antimicrobial Surveillance Program (1997-2001).

scientific article published in September 2003

Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: antimicrobial susceptibility patterns from the SENTRY antimicrobial Surveillance Program (United States and Canada, 1997)

scientific article

Haemophilus influenzae in respiratory tract infections in community-based clinical practice: therapy with gatifloxacin

scientific article published in September 2002

High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center

scientific article published on 16 June 2016

Historical overview of the cephalosporin spectrum: Four generations of structural evolution

Hospital Specificity, Region Specificity, and Fluconazole Resistance of Candida albicans Bloodstream Isolates ⬇️

scientific article published on June 1, 1998

IMP-33, a New IMP variant detected in Pseudomonas aeruginosa from Sicily

scientific article published on 16 September 2013

Identification and antimicrobial susceptibility testing of Branhamella catarrhalis in United States laboratories, 1983-1985

scientific article published on 01 January 1986

Imipenem (N-formimidoyl thienamycin): in vitro antimicrobial activity and beta-lactamase stability

scientific article

Impact of EUCAST, CLSI and USCAST ceftaroline breakpoint changes on the susceptibility of methicillin-resistant Staphylococcus aureus isolates collected from US medical centres (2015-2018)

scientific article published on 31 December 2019

Impact of drug-exposure intensity and duration of therapy on the emergence of Staphylococcus aureus resistance to a quinolone antimicrobial

scientific article published on 2 May 2007

Impact of modified nonmeningeal Streptococcus pneumoniae interpretive criteria (NCCLS M100-S12) on the susceptibility patterns of five parenteral cephalosporins: report from the SENTRY antimicrobial surveillance program (1997 to 2001)

scientific article published on November 2002

Implications of TeqCES: efficacy and safety of gatifloxacin in community-acquired pneumonia

scientific article published in September 2002

Importance of understanding pharmacokinetic/pharmacodynamic principles in the emergence of resistances, including community-associated Staphylococcus aureus.

scientific article

In Vitro Activity and Single-Step Mutational Analysis of Rifamycin SV Tested against Enteropathogens Associated with Traveler's Diarrhea and Clostridium difficile ⬇️

scientific article published on December 13, 2010

In Vitro Activity of Cefepime and Other Broad-Spectrum β-Lactams Tested Against 129 mec A-negative Staphylococcus spp. Isolates: A Multicenter Sample ⬇️

scientific article published on January 1, 1998

In Vitro Activity of Ceftazidime-Avibactam against Contemporary Pseudomonas aeruginosa Isolates from U.S. Medical Centers by Census Region, 2014

scientific article published on 25 January 2016

In Vitro Activity of Dalbavancin against Drug-Resistant Staphylococcus aureus Isolates from a Global Surveillance Program

scientific article published on 18 May 2015

In Vitro Activity of Two Echinocandin Derivatives, LY303366 and MK-0991 (L-743,792), Against Clinical Isolates of Aspergillus, Fusarium, Rhizopus, and Other Filamentous Fungi ⬇️

scientific article published on April 1, 1998

In Vitro Evaluation of HR810, a New Wide-Spectrum Aminothiazolyl α-Methoxyimino Cephalosporin

scientific article published in December 1984

In Vitro Evaluation of Sparfloxacin Activity and Spectrum Against 24,940 Pathogens Isolated in the United States and Canada, the Final Analysis ⬇️

scientific article published on May 1, 1998

In vitro activities of BMS-207147 against over 600 contemporary clinical bloodstream isolates of Candida species from the SENTRY Antimicrobial Surveillance Program in North America and Latin America

scientific article

In vitro activities of ampicillin-sulbactam and cefoperazone-sulbactam against oxacillin-susceptible and oxacillin-resistant staphylococci ⬇️

scientific article

In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin

scientific article

In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolates.

scientific article

In vitro activities of isavuconazole and comparator antifungal agents tested against a global collection of opportunistic yeasts and molds

scientific article published on 05 June 2013

In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans

scientific article

In vitro activities of ravuconazole (BMS-207147) against 541 clinical isolates of Cryptococcus neoformans

scientific article published on October 2000

In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.

scientific article

In vitro activities of the novel cephalosporin LB 11058 against multidrug-resistant Staphylococci and Streptococci

scientific article

In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood.

scientific article

In vitro activity and disk susceptibility of Timentin: current status

scientific article published in November 1985

In vitro activity and spectrum of LY333328, a novel glycopeptide derivative.

scientific article

In vitro activity evaluations of cefdinir (FK482, CI-983, and PD134393). A novel orally administered cephalosporin

scientific article

In vitro activity of 11 antimicrobial agents, including gatifloxacin and GAR936, tested against clinical isolates of Mycobacterium marinum

scientific article published in February 2002

In vitro activity of 43 antimicrobial agents tested against ampicillin-resistant enterococci and gram-positive species resistant to vancomycin

scientific article

In vitro activity of CP-74667 compared with four other fluoroquinolones

scientific article published on 01 August 1992

In vitro activity of DJ-6783 (a keto carboxylic acid) compared with six other orally administered antimicrobial agents

scientific article

In vitro activity of DU-6859a, a new fluorocyclopropyl quinolone

scientific article

In vitro activity of E-4868, a new trifluoroquinolone, compared to six similar compounds

scientific article

In vitro activity of FCE 22101, imipenem, and ceftazidime against over 6,000 bacterial isolates and MIC quality control limits of FCE 22101

scientific article published on 01 December 1988

In vitro activity of RU29246. The metabolite of a new HR916 cephalosporin ester

scientific article published in November 1991

In vitro activity of RX-P873 against Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii

scientific article

In vitro activity of Ro 23-9424, ceftazidime, and eight other newer beta-lactams against 100 gram-positive blood culture isolates

scientific article published on 01 March 1989

In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycin

scientific article published on February 1987

In vitro activity of a new oral glucan synthase inhibitor (MK-3118) tested against Aspergillus spp. by CLSI and EUCAST broth microdilution methods

scientific article

In vitro activity of a new triazole antifungal agent, Sch 56592, against clinical isolates of filamentous fungi ⬇️

scientific article published on January 1, 1998

In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods

scientific article published on 15 August 2011

In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Candida spp. as determined by CLSI broth microdilution method

scientific article published on 22 June 2011

In vitro activity of apalcillin compared with those of piperacillin and carbenicillin against 6,797 bacterial isolates from four separate medical centers

scientific article published on May 1984

In vitro activity of beta-lactam antimicrobial agents in combination with aztreonam tested against metallo-beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter baumannii

scientific article published in December 2005

In vitro activity of carumonam (RO 17-2301), BMY-28142, aztreonam, and ceftazidime against 7,620 consecutive clinical bacterial isolates

scientific article published on 01 November 1986

In vitro activity of cefepime and ceftazidime against 197 nosocomial blood stream isolates of streptococci: A multicenter sample ⬇️

scientific article published on December 1, 1997

In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5556 recent clinical isolates from five medical centers

scientific article published in August 1993

In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).

scientific article published on September 2012

In vitro activity of ceftaroline alone and in combination against clinical isolates of resistant gram-negative pathogens, including beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa

scientific article published on 6 April 2009

In vitro activity of ceftaroline tested against isolates from the Asia-Pacific region and South Africa (2011).

scientific article published on 15 March 2014

In vitro activity of ceftazidime/avibactam against Gram-negative pathogens isolated from pneumonia in hospitalised patients, including ventilated patients

scientific article

In vitro activity of ceftiofur tested against clinical isolates of Escherichia coli and Klebsiella pneumoniae including extended spectrum beta-lactamase producing strains

scientific article published on 01 August 2000

In vitro activity of clarithromycin (TE-031, A-67268) and 14OH-clarithromycin alone and in combination against Legionella species

scientific article published on 01 November 1990

In vitro activity of dalbavancin against multidrug-resistant Staphylococcus aureus and streptococci from patients with documented infections in Europe and surrounding regions (2011-2013).

scientific article published on 12 May 2016

In vitro activity of fidaxomicin (OPT-80) tested against contemporary clinical isolates of Staphylococcus spp. and Enterococcus spp

scientific article published on 22 March 2010

In vitro activity of garenoxacin tested against a worldwide collection of ciprofloxacin-susceptible and ciprofloxacin-resistant Enterobacteriaceae strains (1999-2004).

scientific article published on 23 March 2007

In vitro activity of gatifloxacin tested against anaerobic bacteria by reference agar dilution and Etest methods

scientific article published on 01 September 1999

In vitro activity of iclaprim and comparison agents tested against Neisseria gonorrhoeae including medium growth supplement effects

scientific article published on March 2009

In vitro activity of levofloxacin and FK-037 against aerobic isolates from spontaneous bacterial peritonitis

scientific article published on 01 June 1995

In vitro activity of linezolid as assessed through the 2013 LEADER surveillance program

scientific article published on 30 December 2014

In vitro activity of mezlocillin and azlocillin compared with that of four other penicillins and two aminoglycosides.

scientific article published in January 1980

In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program

scientific article

In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureus

scientific article published on 21 February 2008

In vitro activity of quinupristin/dalfopristin (RP 59500) against a large collection of infrequently isolated or tested species

scientific article published on 01 July 1996

In vitro activity of selected cephalosporins and erythromycin against staphylococci and pneumococci isolated at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998

scientific article published on 01 June 2000

In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates

scientific article

In vitro activity of the aryl-fluoroquinolones A-56619 and A-56620 and evaluation of disk susceptibility tests

scientific article published in February 1986

In vitro activity of three carbapenem antibiotics. Comparative studies with biapenem (L-627), imipenem, and meropenem against aerobic pathogens isolated worldwide

scientific article published in November 1993

In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates

scientific article

In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centers ⬇️

scientific article published on 01 June 1984

In vitro activity of tigecycline (GAR-936) tested against 11,859 recent clinical isolates associated with community-acquired respiratory tract and gram-positive cutaneous infections

scientific article published in July 2004

In vitro activity of tigecycline, a new glycylcycline, tested against 1,326 clinical bacterial strains isolated from Latin America

scientific article published on October 2005

In vitro antibacterial spectrum of E1040 compared with those of cefpirome and ceftazidime and disk diffusion interpretive criteria for E1040.

scientific article

In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.

scientific article

In vitro antimicrobial activity and MIC quality control guidelines of RPR 106972 (RPR 112808/RPR106950): A novel orally administered streptogramin combination ⬇️

scientific article published on 01 July 1997

In vitro antimicrobial activity evaluation of cefodizime (HR221), a new semisynthetic cephalosporin

scientific article published on December 1981

In vitro antimicrobial activity of CP-99433 compared with other fluoroquinolones

scientific article

In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum beta-lactamases

scientific article

In vitro antimicrobial activity of RU-59863, A C-7 catechol substituted cephalosporin ⬇️

scientific article published on 01 June 1997

In vitro antimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria

scientific article published on 7 December 2015

In vitro antimicrobial activity of cefoperazone-sulbactam combinations against 554 clinical isolates including a review and beta-lactamase studies

scientific article

In vitro antimicrobial activity of sparfloxacin (AT-4140, CI-978, PD 131501) compared with numerous other quinolone compounds

scientific article

In vitro antimicrobial activity of tigemonam, a new orally administered monobactam

scientific article

In vitro antimicrobial activity of tioconazole and its concentrations in vaginal fluids following topical (vagistat-1 6.5%) application

scientific article

In vitro antimicrobial findings for fusidic acid tested against contemporary (2008-2009) gram-positive organisms collected in the United States

scientific article published on 01 June 2011

In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sulbactam combination.

scientific article published on September 1987

In vitro antimicrobial susceptibility testing using 30 microG and 75 microG U63196-E (cefpimizole AC-1370) disks

scientific article

In vitro assessment of gatifloxacin spectrum and potency tested against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae isolates from the Asia-Western Pacific component of the SENTRY antimicrobial surveillance program (19

scientific article published in August 2002

In vitro comparative antimicrobial activity of cefpimizole against clinical isolates from five medical centers

scientific article published on June 1985

In vitro comparison activity of OPC-17116, a new fluoroquinolone, against more than 5,000 recent clinical isolates from five medical centers

scientific article published in October 1993

In vitro comparison of E4868, a new trifluoroquinolone, with ciprofloxacin and temafloxacin tested against 5192 recent clinical isolates from five medical centers

scientific article published on 01 November 1993

In vitro comparison of GR69153, a novel catechol-substituted cephalosporin, with ceftazidime and ceftriaxone against 5,203 recent clinical isolates

scientific article published on July 1991

In vitro efficacy of levofloxacin alone or in combination tested against multi-resistant Pseudomonas aeruginosa strains

scientific article published on 01 December 1996

In vitro efficacy of six cephalosporins tested against Enterobacteriaceae isolated at 38 North American medical centres participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998.

scientific article published in July 2000

In vitro evaluation of A-56619 and A-56620, two new quinolones

scientific article published on January 1986

In vitro evaluation of AZD2563, a new oxazolidinone, tested against beta-haemolytic and viridans group streptococci

scientific article published in June 2002

In vitro evaluation of AZD2563, a new oxazolidinone, tested against unusual gram-positive species

scientific article published in February 2002

In vitro evaluation of AZD2563, a novel oxazolidinone, against 603 recent staphylococcal isolates

scientific article

In vitro evaluation of Augmentin by broth microdilution and disk diffusion susceptibility testing: regression analysis, tentative interpretive criteria, and quality control limits

scientific article published on July 1983

In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococci

scientific article

In vitro evaluation of BI 397, a novel glycopeptide antimicrobial agent

scientific article published in June 2001

In vitro evaluation of CENTA, a new beta-lactamase-susceptible chromogenic cephalosporin reagent.

scientific article published on May 1982

In vitro evaluation of DV-7751a, a new fluoroquinolone with an enhanced spectrum of activity against gram-positive aerobic organisms and anaerobes

scientific article

In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporin

scientific article published on June 1984

In vitro evaluation of LY127935 (6059S) compared with cefotaxime, eight other β-lactams and two aminoglycosides ⬇️

scientific article published on 01 November 1980

In vitro evaluation of WIN 57273, a new broad-spectrum fluoroquinolone

scientific article

In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004

scientific article

In vitro evaluation of a novel orally administered cephalosporin (cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae ⬇️

scientific article published on August 1, 1998

In vitro evaluation of broad-spectrum beta-lactams in the philippines medical centers: role of fourth-generation cephalosporins. The Philippines Antimicrobial Resistance Study Group

scientific article

In vitro evaluation of broad-spectrum beta-lactams tested in medical centers in Korea: role of fourth-generation cephalosporins. The Korean Antimicrobial Resistance Study Group

scientific article published on 01 December 1999

In vitro evaluation of cefepime and other broad-spectrum beta-lactams for isolates in Malaysia and Singapore medical centers. The Malaysia/Singapore Antimicrobial Resistance Study Group

scientific article

In vitro evaluation of cefepime and other broad-spectrum beta-lactams in 22 medical centers in Japan: a phase II trial comparing two annual organism samples. The Japan Antimicrobial Resistance Study Group

scientific article published in December 1999

In vitro evaluation of cefepime and other broad-spectrum beta-lactams in Taiwan medical centers. The Taiwan Antimicrobial Resistance Study Group

scientific article published on 01 December 1999

In vitro evaluation of cefepime and other broad-spectrum beta-lactams in eight medical centers in Thailand. The Thailand Antimicrobial Resistance Study Group

scientific article published in December 1999

In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteria

scientific article published on 01 July 1986

In vitro evaluation of contemporary beta-lactam drugs tested against viridans group and beta-haemolytic streptococci

scientific article published on 01 April 1997

In vitro evaluation of pyridine-2-azo-p-dimethylaniline cephalosporin, a new diagnostic chromogenic reagent, and comparison with nitrocefin, cephacetrile, and other beta-lactam compounds

scientific article published on April 1982

In vitro evaluation of ramoplanin (A16686 or MDL62198). A new depsipeptide complex for potential topical use.

scientific article published in May 1989

In vitro evaluation of three new macrolide antimicrobial agents, RU28965, RU29065, and RU29702, and comparisons with other orally administered drugs

scientific article published on August 1983

In vitro evaluations of U-76,252 (CS-807): antimicrobial spectrum, beta-lactamase stability, and enzyme inhibition

scientific article published on December 1987

In vitro interaction between the penem FCE 22101 and ceftazidime

scientific article published in December 1988

In vitro potency evaluations of various piperacillin/tazobactam generic products compared with the contemporary branded (Zosyn, Wyeth) formulation

scientific article published on 24 January 2008

In vitro potency of doripenem tested against an international collection of rarely isolated bacterial pathogens

scientific article published in April 2009

In vitro spectrum of pexiganan activity when tested against pathogens from diabetic foot infections and with selected resistance mechanisms

scientific article

In vitro spectrum of pexiganan activity; bactericidal action and resistance selection tested against pathogens with elevated MIC values to topical agents

scientific article published on 16 June 2016

In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147, Sch 56592, and voriconazole

scientific article

In vitro susceptibility test practices with Haemophilus influenzae among College of American Pathologists survey participants in the United States

scientific article published on 01 July 1993

In vitro susceptibility testing and quality control parameters for sarafloxacin (A-56620): a fluoroquinolone used for treatment and control of colibacillosis in poultry ⬇️

scientific article published on 01 September 1998

In-vitro activities of gatifloxacin, sparfloxacin and trovafloxacin against 103 strains of Legionella spp

scientific article published on 01 November 1998

In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents

scientific article

In-vitro activity of FK-037, a new parenteral cephalosporin

scientific article published on 01 January 1994

In-vitro activity of LY264826, an investigational glycopeptide antibiotic, against gram-positive bloodstream isolates and selected gram-negative bacilli

scientific article published in May 1992

In-vitro activity of OPC-17116 against more than 6000 consecutive clinical isolates: a multicentre international study

scientific article published in March 1994

In-vitro activity of a combination of two oral beta-lactams (cefpodoxime and amoxycillin) against Streptococcus pneumoniae isolates with reduced susceptibilities to penicillin

scientific article published in October 1998

In-vitro activity of the penem, FCE 22101, and tentative interpretive criteria for disc susceptibility tests

scientific article published on 01 March 1989

In-vitro activity of trovafloxacin (CP99,219) tested by two methods against 150 vancomycin-resistant enterococcal isolates

scientific article published on 01 April 1996

In-vitro comparison of DU-6859a, a novel fluoroquinolone, with other quinolones and oral cephalosporins tested against 5086 recent clinical isolates

scientific article published on 01 December 1993

In-vitro evaluation of Sch 34343: antimicrobial activity, beta-lactamase stability and inhibition

scientific article published in June 1985

In-vitro studies of meropenem

scientific article published on 01 September 1989

In-vitro susceptibility of the Bacteroides fragilis group to cefoperazone, ampicillin, ticarcillin and amoxycillin combined with beta-lactamase inhibitors.

scientific article published in January 1986

In71, an Enterobacter cloacae blaVIM-1 -Carrying Integron Related to In70.2 from Italian Pseudomonas aeruginosa Isolates: A SENTRY Antimicrobial Surveillance Program Report

article

Increased antimicrobial susceptibility profiles among polymyxin-resistant Acinetobacter baumannii clinical isolates

scientific article published on 01 April 2008

Increased resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: time for local guidelines?

scientific article

Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centres: 5 year report of the SENTRY Antimicrobial Surveillance Program (1997-2001)

scientific article published on 29 May 2003

Inducible amp C β-lactamase producing gram-negative bacilli from blood stream infections: Frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE) ⬇️

scientific article published on 01 August 1997

Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivo

scientific article published on October 1987

Influence of growth medium on the in vitro activities of second- and third-generation cephalosporins against Streptococcus faecalis

scientific article published on September 1984

Influence of patient age on the frequency of occurrence and antimicrobial resistance patterns of isolates from hematology/oncology patients: report from the Chemotherapy Alliance for Neutropenics and the Control of Emerging Resistance Program (North

scientific article published on 28 July 2006

Influence of patient age on the susceptibility patterns of Streptococcus pneumoniae isolates in North America (2000-2001): report from the SENTRY Antimicrobial Surveillance Program ⬇️

scientific article published on May 1, 2003

Influence of polysorbate-80 when determining the tigecycline MIC by the reference method

scientific article published on 26 March 2007

Initial broth microdilution quality control guidelines for Debio 1452, a FabI inhibitor antimicrobial agent

scientific article published on 31 August 2015

Initial disk diffusion quality control guidelines for tylosin tested against Staphylococcus aureus ATCC 25923 and Streptococcus pneumoniae ATCC 49619

scientific article published on 01 June 2003

Initial quality control evaluations for susceptibility testing of Dalbavancin (BI397), an investigational glycopeptide with potent gram-positive activity

scientific article published on June 2003

Initial results from a longitudinal international surveillance programme for anidulafungin (2003).

scientific article published on 25 November 2004

Integration of molecular characterization of microorganisms in a global antimicrobial resistance surveillance program

scientific article

Integron carrying a novel metallo-beta-lactamase gene, blaIMP-16, and a fused form of aminoglycoside-resistant gene aac(6')-30/aac(6')-Ib': report from the SENTRY Antimicrobial Surveillance Program.

scientific article published on December 2004

Interim susceptibility testing for ceftaroline, a new MRSA-active cephalosporin: selecting potent surrogate β-lactam markers to predict ceftaroline activity against clinically indicated species

scientific article published on 28 September 2012

Interlaboratory variations of fluoroquinolone susceptibility testing. An international study to validate the quality of microbiology results reported during the fleroxacin clinical trials

scientific article published in October 1993

International Surveillance of Bloodstream Infections Due to Candida Species: Frequency of Occurrence and Antifungal Susceptibilities of Isolates Collected in 1997 in the United States, Canada, and South America for the SENTRY Program ⬇️

scientific article published on July 1, 1998

International surveillance of Candida spp. and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2003).

scientific article

International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group

scientific article published on 01 September 1999

International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobia

scientific article

Interpretative criteria for the agar diffusion susceptibility test with azithromycin

scientific article published in November 1988

Interpretive accuracy of the disk diffusion method for testing newer orally administered cephalosporins against Morganella morganii.

scientific article published on October 1993

Interpretive categorical accuracy of fluoroquinolone reference broth microdilution MIC results when testing Streptococcus pneumoniae: selection of a surrogate testing agent

scientific article

Interpretive criteria and quality control guidelines for Neisseria gonorrhoeae susceptibility test standardization for cefotetan

scientific article published on February 1991

Interpretive criteria and quality control limits for ceftibuten disk susceptibility tests. Collaborative Antimicrobial Susceptibility Testing Group

scientific article published on March 1990

Interpretive criteria and tentative quality control limits for apalcillin disk susceptibility tests.

scientific article published on June 1984

Interpretive criteria for DU-6859a disk diffusion tests using 5-micrograms disks

scientific article published on 01 February 1994

Interpretive criteria for cefodizime in vitro susceptibility tests with Neisseria gonorrhoeae

scientific article published on 01 October 1993

Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic

scientific article published on March 1990

Interpretive criteria for disk diffusion tests using 5-microgram cefdinir disks with rapidly growing clinical isolates

scientific article published on April 1992

Interpretive criteria for susceptibility tests with DU-6859a and FK-037 tested against Haemophilus influenzae and Neisseria gonorrhoeae

scientific article published on 01 June 1994

Interpretive criteria for temocillin disk diffusion susceptibility testing

scientific article

Interpretive criteria, quality control guidelines, and drug stability studies for susceptibility testing of cefotaxime, cefoxitin, ceftazidime, and cefuroxime against Neisseria gonorrhoeae

scientific article published in November 1990

Interpretive errors using an automated system for the susceptibility testing of imipenem and aztreonam

scientific article

Interpretive standards and quality control guidelines for cefpiramide disk susceptibility tests

scientific article published on October 1985

Interpretive standards and quality control guidelines for imipenem susceptibility tests with 10-micrograms disks

scientific article

Interpretive standards and quality control limits for susceptibility tests with ampicillin-sulbactam combination disks ⬇️

scientific article published on February 1, 1984

Interpretive standards of cefbuperazone disk diffusion susceptibility tests

Isavuconazole and nine comparator antifungal susceptibility profiles for common and uncommon Candida species collected in 2012: application of new CLSI clinical breakpoints and epidemiological cutoff values

scientific article published on 21 June 2014

Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints an

scientific article published on 29 April 2015

Italian metallo-beta-lactamases: a national problem? Report from the SENTRY Antimicrobial Surveillance Programme.

scientific article

JNJ-Q2, a New Fluoroquinolone with Potent In Vitro Activity against Staphylococcus aureus, Including Methicillin- and Fluoroquinolone-Resistant Strains ⬇️

scientific article published on May 9, 2011

Klebsiella pneumoniae Isolate from a New York City Hospital Belonging to Sequence Type 258 and Carrying blaKPC-2 and blaVIM-4.

scientific article published on 4 January 2016

Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae testing susceptible to cefepime by reference methods

scientific article published on 24 April 2013

LEADER Program Results for 2009: an Activity and Spectrum Analysis of Linezolid Using 6,414 Clinical Isolates from 56 Medical Centers in the United States ⬇️

scientific article published on June 13, 2011

LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers)

scientific article published on 27 August 2007

LEADER surveillance program results for 2010: an activity and spectrum analysis of linezolid using 6801 clinical isolates from the United States (61 medical centers).

scientific article published on 15 June 2012

LY164846 in vitro antimicrobial activity testing, including disk diffusion susceptibility tests using 30-microgram disks

scientific article published on March 1986

Linezolid Surveillance Results for the United States (LEADER Surveillance Program 2014).

scientific article published on February 2016

Linezolid resistance since 2001: SENTRY Antimicrobial Surveillance Program

scientific article published in June 2003

Linezolid surveillance program results for 2008 (LEADER Program for 2008).

scientific article published in December 2009

Linezolid surveillance results for the United States: LEADER surveillance program 2011.

scientific article published on 17 December 2012

Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms

scientific article

Linezolid-resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone: report from the SENTRY Antimicrobial Surveillance Program

scientific article published in February 2002

Longitudinal (2001-14) analysis of enterococci and VRE causing invasive infections in European and US hospitals, including a contemporary (2010-13) analysis of oritavancin in vitro potency

scientific article published on 8 September 2016

Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strains

scientific article published on 5 April 2010

MIC quality control guidelines and disk diffusion test optimization for CEM-101, a novel fluoroketolide

scientific article

MIC quality control guidelines for doxycycline when testing gram-positive control strains by the reference methods

scientific article published in December 2004

MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from the Americas: resistance implications in the treatment of serious infections

scientific article published in August 2000

MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from the Americas: resistance implications in the treatment of serious infections. MYSTIC Study Group (Americas)

scientific article published in September 2000

Macrolide and fluoroquinolone (levofloxacin) resistances among Streptococcus pneumoniae strains: significant trends from the SENTRY Antimicrobial Surveillance Program (North America, 1997-1999).

scientific article published on November 2000

Macrolide and tetracycline resistance among Moraxella catarrhalis isolates from 2009 to 2011.

scientific article published on 20 July 2012

Mechanisms of Resistance, Clonal Expansion, and Increasing Prevalence of Acinetobacter baumannii Strains Displaying Elevated Tigecycline MIC Values in Latin America

scientific article

Medium-dependent zone size discrepancies associated with susceptibility testing of group D streptococci against various cephalosporins

scientific article published on October 1983

Metallo-beta-lactamase IMP-18 is located in a class 1 integron (In96) in a clinical isolate of Pseudomonas aeruginosa from Mexico

scientific article published on 29 October 2007

Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico

scientific article published on 19 May 2008

Methicillin-resistant Staphylococcus aureus outbreak in a veterinary teaching hospital: potential human-to-animal transmission

scientific article

Methicillin-resistant Staphylococcus aureus: implications for the 1990s and effective control measures

scientific article

Mezlocillin: tentative interpretive standards for disk diffusion susceptibility testing

scientific article published on August 1981

Microbiologic characterization of isolates from a dalbavancin clinical trial for catheter-related bloodstream infections

scientific article published in February 2006

Microbiological Assessment of Polymyxin B Components Tested Alone and in Combination

scientific article published on 21 September 2015

Microbiological and epidemiological characterization of imipenem-resistant Pseudomonas aeruginosa strains from a Brazilian tertiary hospital: report from the SENTRY Antimicrobial Surveillance Program

scientific article published in October 2006

Minimum inhibitory concentration quality-control guidelines for biapenem, DU-6859a, FK-037, levofloxacin, grepafloxacin, and ceftizoxime when using various National Committee for Clinical Laboratory Standards susceptibility test methods. Quality Con

scientific article

Minocycline activity tested against Acinetobacter baumannii complex, Stenotrophomonas maltophilia, and Burkholderia cepacia species complex isolates from a global surveillance program (2013).

scientific article published on 31 March 2016

Modification of interpretive breakpoints for netilmicin disk susceptibility tests with Pseudomonas aeruginosa.

scientific article published on March 1984

Modifications for disk diffusion susceptibility testing criteria of clinafloxacin (CI-960, AM-1091, PD127371) and fleroxacin (Ro 23-6240, AM-833) following studies with a challenge panel of ciprofloxacin-resistant clinical isolates

scientific article published in April 1995

Molecular and biochemical characterization of OXA-45, an extended-spectrum class 2d' beta-lactamase in Pseudomonas aeruginosa.

scientific article published on September 2003

Molecular characterization of SPM-1, a novel metallo-beta-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme

scientific article

Molecular characterization of Staphylococcus aureus isolates from a 2005 clinical trial of uncomplicated skin and skin structure infections

scientific article

Molecular characterization of a beta-lactamase gene, blaGIM-1, encoding a new subclass of metallo-beta-lactamase.

scientific article published on December 2004

Molecular characterization of vancomycin-resistant Enterococcus spp. clinical isolates recovered from hospitalized patients among several medical institutions in China ⬇️

scientific article published on October 23, 2012

Molecular epidemiology and antimicrobial susceptibility testing. Testing of quinolone-resistant Staphylococcus aureus strains isolated in Brazil

scientific article published on 01 January 1993

Molecular epidemiology of extended-spectrum beta-lactamase-producing, fluoroquinolone-resistant isolates of Klebsiella pneumoniae in Taiwan

scientific article

Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococci

scientific article published in June 2003

Molecular epidemiology of selected multidrug-resistant bacteria: a global report from the SENTRY Antimicrobial Surveillance Program

scientific article

Molecular typing and antimicrobial susceptibility of vancomycin-resistant Enterococcus faecium in Brazil

scientific article published in January 2002

More potency assay results for generic non-USA lots of piperacillin/tazobactam and initial reports for generic meropenem compounds marketed in the USA ⬇️

scientific article published on March 13, 2013

Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin

scientific article published on April 1980

Multi-center validation of proposed disk diffusion susceptibility testing interpretive criteria for lomefloxacin using more than 1,500 clinical isolates

scientific article published on 01 March 1996

Multi-laboratory assessment of the linezolid spectrum of activity using the Kirby-Bauer disk diffusion method: Report of the Zyvox Antimicrobial Potency Study (ZAPS) in the United States

scientific article published in May 2001

Multicenter Investigation of Gepotidacin (GSK2140944) Agar Dilution Quality Control Determinations for Neisseria gonorrhoeae ATCC 49226.

scientific article published on 9 May 2016

Multicenter assessment of the linezolid spectrum and activity using the disk diffusion and Etest methods: report of the Zyvox(R) antimicrobial potency study in Latin America (LA-ZAPS).

scientific article published in June 2002

Multicenter comparison of in vitro activities of FK-037, cefepime, ceftriaxone, ceftazidime, and cefuroxime

scientific article published in August 1993

Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group

scientific article published on December 1997

Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia: comparison of data from 1997 and 1998 using the Etest method. The Colombian Antimicrobial Resistance Study Group

scientific article

Multicenter evaluation of the Etest and disk diffusion methods for differentiating daptomycin-susceptible from non-daptomycin-susceptible Staphylococcus aureus isolates

scientific article published on September 2006

Multicenter evaluation of the antimicrobial activity for seven broad-spectrum beta-lactams in Turkey using the Etest method. Turkish Antimicrobial Resistance Study Group

scientific article

Multicenter evaluation of the antimicrobial activity for six broad-spectrum beta-lactams in Venezuela using the Etest method. The Venezuelan Antimicrobial Resistance Study Group

scientific article published on January 1998

Multicenter evaluation of the antimicrobial activity for six broad-spectrum beta-lactams in Venezuela: comparison of data from 1997 and 1998 using the Etest method. Venezuelan Antimicrobial Resistance Study Group

scientific article

Multicenter evaluation of the in vitro activity of dalbavancin tested against staphylococci and streptococci in 5 European countries: results from the DECIDE Surveillance Program (2007).

scientific article published on 26 February 2009

Multicenter evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents in Puerto Rico. The Puerto Rico Antimicrobial Resistance Study Group

scientific article published on 01 February 1998

Multicenter in vitro evaluation of SM-7338, a new carbapenem

scientific article

Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing

scientific article

Multicenter laboratory evaluation of the bioMérieux Vitek antimicrobial susceptibility testing system with 11 antimicrobial agents versus members of the family Enterobacteriaceae and Pseudomonas aeruginosa ⬇️

scientific article published on August 1, 1997

Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp.

scientific article published on 8 November 2006

Multicentre assessment of linezolid antimicrobial activity and spectrum in Europe: report from the Zyvox antimicrobial potency study (ZAPS-Europe).

scientific article

Multicentre evaluation of the in vitro activity of linezolid in the Western Pacific

scientific article

Multilaboratory evaluation of the in vitro activity of 13 beta-lactam antibiotics against 1474 clinical isolates of aerobic and anaerobic bacteria

scientific article published on 01 March 1993

Mutation-driven β-lactam resistance mechanisms among contemporary ceftazidime-nonsusceptible Pseudomonas aeruginosa isolates from U.S. hospitals

scientific article published on 2 September 2014

National Surveillance of Nosocomial Blood Stream Infection Due to Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE Program ⬇️

scientific article published on May 1, 1998

Neisseria meningitidis with decreased susceptibility to penicillin: Report from the SENTRY antimicrobial surveillance program, North America, 1998–99 ⬇️

scientific article published on September 1, 2001

Netilmicin disk susceptibility tests: effect of cations on the MIC correlates

scientific article published on 01 August 1987

Newer glycopeptide antibiotics tested against nosocomial bloodstream isolates

scientific article published on 01 March 1993

Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus

scientific article published on 27 April 2009

Noninvasive Streptococcus pneumoniae serotypes recovered from hospitalized adult patients in the United States in 2009 to 2012.

scientific article published on 29 June 2015

Norfloxacin (MK-0366, AM-715): In vitro activity and cross-resistance with other organic acids including quality control limits for disk diffusion testing ⬇️

scientific article published on June 1, 1983

North American (United States and Canada) comparative susceptibility of two fluoroquinolones: ofloxacin and ciprofloxacin. A 53-medical-center sample of spectra of activity. North American Ofloxacin Study Group

scientific article

Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility

scientific article published on 01 September 2000

Nosocomial bloodstream infections in United States hospitals: a three-year analysis

scientific article published in August 1999

Nosocomial enterococcal blood stream infections in the SCOPE program: Antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy ⬇️

scientific article published on October 1, 1997

Nosocomial transmission of Serratia odorifera biogroup. 2: Case report demonstration by macrorestriction analysis of chromosomal DNA using pulsed-field gel electrophoresis

scientific article published on 01 June 1994

OXA-163, an OXA-48-related class D β-lactamase with extended activity toward expanded-spectrum cephalosporins

scientific article published on 21 March 2011

Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002).

scientific article

Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000) ⬇️

scientific article published on April 1, 2003

Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004).

scientific article published in January 2006

Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008).

scientific article published on 29 April 2010

Occurrence of plasmidic AmpC type beta-lactamase-mediated resistance in Escherichia coli: report from the SENTRY Antimicrobial Surveillance Program (North America, 2004).

scientific article

Occurrence of single-point gyrA mutations among ciprofloxacin-susceptible Escherichia coli isolates causing urinary tract infections in Latin America

scientific article published in January 2000

Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals

scientific article published on 10 September 2009

Ofloxacin susceptibility testing quality control parameters for microdilution and disk diffusion, and confirmation of disk diffusion interpretive criteria.

scientific article published on January 1989

Ofloxacin, a new broad-spectrum fluoroquinolone. Results from a Multicenter, National Comparative Activity Surveillance Study. The Ofloxacin Surveillance Group

scientific article published in July 1992

Old In Vitro Antimicrobial Breakpoints Are Misleading Stewardship Efforts, Delaying Adoption of Innovative Therapies, and Harming Patients

scientific article published on 13 March 2020

Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide: spectrum of antimicrobial activity and measurements of bactericidal activity

scientific article published on August 2004

Optimal cefotaxime dosing for gram-negative bacteremia: effective trough serum bactericidal titers and drug concentrations 8 and 12 hr after 1- or 2-gm infusions

scientific article published in February 1988

Optimal dilution susceptibility testing conditions, recommendations for MIC interpretation, and quality control guidelines for the ampicillin-sulbactam combination

scientific article published on October 1987

Oral beta-lactams applied to uncomplicated infections of skin and skin structures

scientific article published on 9 February 2007

Oritavancin Activity Tested against Molecularly Characterized Staphylococci and Enterococci Displaying Elevated Linezolid MIC Results

scientific article published on 21 March 2016

Oritavancin Microbiologic Features and Activity Results From the Surveillance Program in the United States ⬇️

scientific article published on 01 April 2012

Oritavancin activity against Staphylococcus aureus causing invasive infections in U.S. and European hospitals: a 5-year international surveillance program

scientific article published on 18 February 2014

Oritavancin activity against vancomycin-susceptible and vancomycin-resistant Enterococci with molecularly characterized glycopeptide resistance genes recovered from bacteremic patients, 2009-2010

scientific article published on 19 December 2011

Oritavancin in vitro activity against contemporary Staphylococcus aureus isolates responsible for invasive community- and healthcare-associated infections among patients in the United States (2013-2014).

scientific article published on 27 July 2016

Outbreak of Pseudomonas aeruginosa infections in a surgical intensive care unit: probable transmission via hands of a health care worker

scientific article published on 01 March 1993

Outcomes evaluation of patients with ESBL- and non-ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: report from the SENTRY Antimicrobial Surveillance Program

scientific article published on 19 January 2006

Oxacillin- and quinolone-resistant Staphylococcus aureus in Sao Paulo, Brazil: a multicenter molecular epidemiology study

scientific article

Oxazolidinone antibiotics.

scientific article published in December 2001

Oxazolidinone susceptibility patterns for 2005: International Report from the Zyvox Annual Appraisal of Potency and Spectrum Study

scientific article published on 18 January 2007

Oxazolidinone susceptibility patterns in 2004: report from the Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program assessing isolates from 16 nations

scientific article published on 2 December 2005

Oxazolidinones: a review

scientific article

Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY antimicrobial surveillance program ⬇️

scientific article published on March 7, 2003

Pathogen occurrence and antimicrobial resistance trends among urinary tract infection isolates in the Asia-Western Pacific Region: report from the SENTRY Antimicrobial Surveillance Program, 1998-1999.

scientific article

Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000) ⬇️

scientific article published on April 1, 2003

Performance accuracy of antibacterial and antifungal susceptibility test methods: report from the College of American Pathologists Microbiology Surveys Program (2001-2003).

scientific article

Performance of BD Max StaphSR for Screening of Methicillin-Resistant Staphylococcus aureus Isolates among a Contemporary and Diverse Collection from 146 Institutions Located in Nine U.S. Census Regions: Prevalence of mecA Dropout Mutants

scientific article

Performance of fusidic acid (CEM-102) susceptibility testing reagents: broth microdilution, disk diffusion, and Etest methods as applied to Staphylococcus aureus

scientific article published on 6 January 2010

Pharmacodynamic considerations in the treatment of moderate to severe pseudomonal infections with cefepime

scientific article

Pharmacodynamics in the evaluation of drug regimens

scientific article published on 01 March 2002

Pharmacodynamics of cefprozil against Haemophilus influenzae in an in vitro pharmacodynamic model

scientific article published on 23 August 2006

Pharmacodynamics of ceftazidime and meropenem in cerebrospinal fluid: results of population pharmacokinetic modelling and Monte Carlo simulation

scientific article published on 04 September 2007

Pharmacodynamics of β-lactamase inhibition by NXL104 in combination with ceftaroline: examining organisms with multiple types of β-lactamases

scientific article published on 24 October 2011

Pharmacokinetic and pharmacodynamic profile of ceftobiprole.

scientific article published on 02 April 2008

Pharmacokinetics of single-dose ceftaroline fosamil in children with cystic fibrosis

scientific article published on 14 September 2017

Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in an In Vitro Infection Model

scientific article published on 19 January 2016

Pharmacokinetics-pharmacodynamics of tazobactam in combination with ceftolozane in an in vitro infection model

scientific article published on 29 April 2013

Pharmacological basis of β-lactamase inhibitor therapeutics: tazobactam in combination with Ceftolozane

scientific article published on 16 September 2013

Phenotypic and genotypic characterizations of Chinese strains of Escherichia coli producing extended-spectrum beta-lactamases

scientific article published in July 1999

Phenotypic detection of mec A-positive staphylococcal blood stream isolates: high accuracy of simple disk diffusion tests

scientific article published on 01 July 1996

Piperacillin (T-1220), a new semisynthetic penicillin. II. In vitro antimicrobial activity and synergy comparison with carbenicillin and gentamicin

scientific article published on 01 January 1979

Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin

scientific article published on 01 December 1977

Piperacillin/tazobactam (YTR 830) combination. Comparative antimicrobial activity against 5889 recent aerobic clinical isolates and 60 Bacteroides fragilis group strains

scientific article published on 01 November 1989

Plasmid-borne vga(A)-encoding gene in methicillin-resistant Staphylococcus aureus ST398 recovered from swine and a swine farmer in the United States

scientific article published in October 2011

Polymyxin Susceptibility Testing and Interpretive Breakpoints: Recommendations from the United States Committee on Antimicrobial Susceptibility Testing (USCAST)

scientific article published on 27 January 2020

Polymyxins: wisdom does not always come with age.

scientific article published on 11 July 2013

Post-β-lactamase-inhibitor effect of tazobactam in combination with ceftolozane on extended-spectrum-β-lactamase-producing strains

scientific article published on 21 January 2014

Postantibiotic effects of E-4868 and OPC-17116.

scientific article

Potencies of newer fluoroquinolones against Viridans group Streptococciisolated in 637 cases of bloodstream infection in the SENTRY Antimicrobial Surveillance Program (1997 to 1999): beyond Canada!

scientific article published on October 2000

Potency and antimicrobial spectrum update for piperacillin/tazobactam (2000): emphasis on its activity against resistant organism populations and generally untested species causing community-acquired respiratory tract infections

scientific article published in May 2002

Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates

scientific article published on 16 March 2009

Potency and spectrum of activity of AN3365, a novel boron-containing protein synthesis inhibitor, tested against clinical isolates of Enterobacteriaceae and nonfermentative Gram-negative bacilli

scientific article published on 18 March 2013

Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004).

scientific article published on 23 March 2007

Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004).

scientific article

Potency and spectrum reevaluation of cefdinir tested against pathogens causing skin and soft tissue infections: a sample of North American isolates

scientific article

Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003).

scientific article published in July 2005

Potency of anidulafungin compared to nine other antifungal agents tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: results from the global SENTRY Antimicrobial Surveillance Program (2008).

scientific article published on 9 June 2010

Potential synergy activity of the novel ceragenin, CSA-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa

scientific article published on 12 December 2007

Potential utility of a peptide deformylase inhibitor (NVP PDF-713) against oxazolidinone-resistant or streptogramin-resistant Gram-positive organism isolates

scientific article published on 31 March 2004

Practical approach to the identification of clinically relevant Enterococcus species

article

Pre-clinical development of antifungal susceptibility test methods for the testing of the novel antifungal agent E1210 versus Candida: comparison of CLSI and European Committee on Antimicrobial Susceptibility Testing methods

scientific article published on 25 August 2011

Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8074) and cefteram (Ro 19-5247) disk tests

scientific article published on September 1987

Preliminary interpretive criteria for disk diffusion susceptibility testing of SCH 27899, a compound in the everninomicin class of antimicrobial agents ⬇️

scientific article published on 01 December 1995

Preliminary susceptibility testing guidelines for AZD2563, a long-acting oxazolidinone

scientific article

Premafloxacin: a projected veterinary use fluoro-quinolone with significant activity against multi-resistant gram-positive human pathogens

scientific article published on 01 October 1996

Prevalence and antimicrobial susceptibility patterns among gastroenteritis-causing pathogens recovered in Europe and Latin America and Salmonella isolates recovered from bloodstream infections in North America and Latin America: report from the SENT

scientific article published on May 2006

Prevalence and significance of a negative extended-spectrum beta-lactamase (ESBL) confirmation test result after a positive ESBL screening test result for isolates of Escherichia coli and Klebsiella pneumoniae: results from the SENTRY Asia-Pacific S

scientific article published on 7 March 2007

Prevalence of Antimicrobial Resistance Among Respiratory Tract Isolates ofStreptococcus pneumoniaein North America: 1997 Results from the SENTRY Antimicrobial Surveillance Program ⬇️

scientific article published on 01 October 1998

Prevalence of antimicrobial resistance among respiratory tract isolates in Latin America: results from SENTRY antimicrobial surveillance program (1997-98)

scientific article published on 01 October 2000

Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99).

scientific article

Prevalence of extended-spectrum beta-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001.

scientific article

Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States, I. Study on the threat of emerging resistances: real or perceived? Fluoroquinolone Resistance Surveillance Group.

scientific article

Prevalence of important pathogens and the antimicrobial activity of parenteral drugs at numerous medical centers in the United States. II. Study of the intra- and interlaboratory dissemination of extended-spectrum beta-lactamase-producing Enterobact

scientific article published on 01 December 1994

Prevalence of macrolide-lincosamide resistance and multidrug resistance phenotypes in streptococcal isolates causing infections in European hospitals: Evaluation of the in vitro activity of oritavancin and comparator agents

scientific article published on 2 November 2016

Prevalence of β-lactamase-encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 U.S. hospitals: report from the SENTRY Antimicrobial Surveillance Program (2010).

scientific article published on 15 April 2013

Proposed MIC quality control guidelines for National Committee for Clinical Laboratory Standards susceptibility tests using seven veterinary antimicrobial agents: ceftiofur, enrofloxacin, florfenicol, penicillin G-novobiocin, pirlimycin, premafloxac

scientific article published on August 1996

Proposed changes in interpretive criteria and potency of ampicillin and ampicillin-sulbactam disks for susceptibility tests

scientific article published on April 1988

Proposed disk diffusion susceptibility criteria for ofloxacin.

scientific article published on August 1985

Proposed quality control guidelines for National Committee for Clinical Laboratory Standards Susceptibility Tests using the veterinary antimicrobial agent tiamulin

scientific article published in May 2001

Proposed quality control ranges for 2-microg anidulafungin disk diffusion testing and ability of the method to detect strains with elevated echinocandin MIC values

scientific article

Proposed zone standards for interpretation of fortimicin A disk diffusion tests

scientific article published on August 1983

Pseudomonas aeruginosa strains harbouring an unusual blaVIM-4 gene cassette isolated from hospitalized children in Poland (1998-2001).

scientific article published on 28 January 2004

Pulsed-field gel electrophoresis of restriction-digested genomic DNA and antimicrobial susceptibility of Xanthomonas maltophilia strains from Brazil, Switzerland and the USA

scientific article published on 01 March 1994

Quality Control Guidelines for Amphotericin B, Itraconazole, Posaconazole, and Voriconazole Disk Diffusion Susceptibility Tests with Nonsupplemented Mueller-Hinton Agar (CLSI M51-A Document) for Nondermatophyte Filamentous Fungi ⬇️

scientific article published on May 4, 2011

Quality control MIC ranges used for telavancin with application of a revised CLSI reference broth microdilution method

scientific article published on 11 June 2014

Quality control guidelines for BAL9141 (Ro 63-9141), an investigational cephalosporin, when reference MIC and standardized disk diffusion susceptibility test methods are used

scientific article published on July 2004

Quality control guidelines for Haemophilus test medium MIC susceptibility tests with cefmetazole, cefpodoxime, CI-960 (PD127391, AM-1090), and RU29246.

scientific article published in March 1991

Quality control guidelines for MIC susceptibility testing of NVP PDF-713: a novel peptide deformylase inhibitor

scientific article published on 01 July 2003

Quality control guidelines for MIC susceptibility testing of omiganan pentahydrochloride (MBI 226), a novel antimicrobial peptide

scientific article published in March 2004

Quality control guidelines for amoxicillin, amoxicillin-clavulanate, azithromycin, piperacillin-tazobactam, roxithromycin, ticarcillin, ticarcillin-clavulanate, trovafloxacin (CP 99,219), U-100592, and U-100766 for various National Committee for Cli

scientific article published on 01 February 1996

Quality control guidelines for disk diffusion and broth microdilution antimicrobial susceptibility tests with seven drugs for veterinary applications.

scientific article

Quality control guidelines for susceptibility testing of retapamulin (SB-275833) by reference and standardized methods

scientific article published in December 2005

Quality control guidelines for testing cefotetan in the reference agar dilution procedure for susceptibility testing of anaerobic bacteria

scientific article published on January 1989

Quality control guidelines for testing gram-negative control strains with polymyxin B and colistin (polymyxin E) by standardized methods

scientific article

Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study.

scientific article published on July 1981

Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid

scientific article published on 01 May 1987

Quality control limits for teicoplanin susceptibility tests and confirmation of disk diffusion interpretive criteria

scientific article published on September 1987

Quality control limits for the standard anaerobic reference agar dilution susceptibility test procedure of the National Committee for Clinical Laboratory Standards

scientific article published on January 1989

Quality control of moxalactam susceptibility disks ⬇️

scientific article published on June 1, 1983

Quality control of susceptibility tests with 5-micrograms trimethoprim disks

scientific article published on October 1984

Quality control parameters for susceptibility tests with 30-micrograms netilmicin disks.

scientific article

Quantifying the matrix of relationships between reduced vancomycin susceptibility phenotypes and outcomes among patients with MRSA bloodstream infections treated with vancomycin .

scientific article published on 19 May 2014

Quinupristin-dalfopristin resistance in Streptococcus pneumoniae: novel L22 ribosomal protein mutation in two clinical isolates from the SENTRY antimicrobial surveillance program

scientific article

RO 23-6240 (AM-833), a new fluoroquinolone: in vitro antimicrobial activity and tentative disk diffusion interpretive criteria

scientific article published on 01 May 1987

Rapid emergence of blaCTX-M among Enterobacteriaceae in U.S. Medical Centers: molecular evaluation from the MYSTIC Program (2007).

scientific article published in September 2008

Rapid expansion of KPC-2-producing Klebsiella pneumoniae isolates in two Texas hospitals due to clonal spread of ST258 and ST307 lineages

scientific article published on 26 March 2013

Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: coping with antimicrobial susceptibility in an era of resistance

scientific article published on June 2009

Re-evaluation of quality control guidelines for gatifloxacin and garenoxacin (BMS284756) when susceptibility testing Haemophilus influenzae and Streptococcus pneumoniae

scientific article

Re-evaluation of the role of broad-spectrum cephalosporins against staphylococci by applying contemporary in-vitro results and pharmacokinetic-pharmacodynamic principles

scientific article published on 01 February 2007

Reassessment of susceptibility test interpretive criteria for ticarcillin and ticarcillin-clavulanic acid

scientific article

Reevaluation of Clinical and Laboratory Standards Institute disk diffusion breakpoints for tetracyclines for testing Enterobacteriaceae

scientific article published on 14 March 2007

Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 beta-lactams: adjustments of breakpoints for strains producing extended spectrum beta-lactamases

scientific article published in July 2005

Reevaluation of interpretive criteria for Haemophilus influenzae by using meropenem (10-microgram), imipenem (10-microgram), and ampicillin (2- and 10-microgram) disks

scientific article published on August 1996

Reevaluation of the cefepime minimal inhibitory concentrations and disk diffusion test zone diameter relationship for a worldwide collection of Enterobacteriaceae enriched for extended-spectrum beta-lactamase-producing organisms

scientific article

Reevaluations of disk diffusion susceptibility testing interpretive criteria for lomefloxacin and norfloxacin using fluoroquinolone-resistant isolates

scientific article published in April 1995

Regional data analysis of Candida non-albicans strains collected in United States medical sites over a 6-year period, 2006-2011.

scientific article

Regional pooling of national data from a small number of sites can be misleading: maybe yes? But data can be complimentary to other studies and valuable to infectious disease physicians!

scientific article published on 14 May 2014

Regional resistance surveillance program results for 12 Asia-Pacific nations (2011).

scientific article published on 19 August 2013

Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002).

scientific article published in August 2005

Relapse of catheter-related Flavobacterium meningosepticum bacteremia demonstrated by DNA macrorestriction analysis

scientific article published on 01 October 1995

Relationship between ceftolozane-tazobactam exposure and drug resistance amplification in a hollow-fiber infection model

scientific article published on 17 June 2013

Relationship between ceftolozane-tazobactam exposure and selection for Pseudomonas aeruginosa resistance in a hollow-fiber infection model

scientific article

Relationship between day 1 and day 2 Vancomycin area under the curve values and emergence of heterogeneous Vancomycin-intermediate Staphylococcus aureus (hVISA) by Etest® macromethod among patients with MRSA bloodstream infections: a pilot study

scientific article

Relationship between increased levofloxacin use and decreased susceptibility of Streptococcus pneumoniae in the United States

scientific article published in January 2005

Relationships between patient- and institution-specific variables and decreased antimicrobial susceptibility of Gram-negative pathogens

scientific article published on 17 July 2003

Reliability of cefaclor, cefazolin, cefamandole, and cephalothin disks to predict susceptibility of Enterobacteriaceae, Staphylococcus species, and Haemophilus influenzae

scientific article published in November 1985

Reliability of high-content disks and modified broth dilution tests for detecting staphylococcal resistance to the penicillinase-resistant penicillins

scientific article published on October 1987

Reply to Nation et al.

scientific article

Reply: regional pooling of national data from a small number of sites can be misleading: maybe yes? But data can be complimentary to other studies and valuable to infectious disease physicians!

scientific article

Reproducibility assessment of tigecycline MIC results by broth microdilution methods using commercially prepared dry-form panels

scientific article published in May 2005

Reproducibility of dalbavancin MIC test results and an updated surrogate accuracy analysis of vancomycin MIC values to infer dalbavancin susceptibility (2014)

scientific article published on 09 February 2016

Reproducibility of daptomycin MIC results using dry-form commercial trays with appropriate supplemental calcium content

scientific article published in March 2005

Reproducibility of gemifloxacin and comparison fluoroquinolone MIC results using Sensititre commercial dry-form panels

scientific article

Resistance among important pathogens and the antimicrobial activity of parenteral fluoroquinolones at 43 US medical centres.

scientific article

Resistance surveillance program report for selected European nations (2011).

scientific article published on 14 October 2013

Resistance to beta-lactams among blood isolates of Salmonella spp. in European hospitals: results from the SENTRY Antimicrobial Surveillance Program 1997-98.

scientific article

Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program

scientific article

Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia in Latin America: frequency of occurrence and antimicrobial susceptibility profile: results from the SENTRY Antimicrobial Surveillance Program (1997-2000).

scientific article

Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)

scientific article published on 01 June 2000

Results from Oritavancin Resistance Surveillance Programs (2011 to 2014): Clarification for Using Vancomycin as a Surrogate To Infer Oritavancin Susceptibility.

scientific article

Results from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme: report of the 2001 data from 15 United States medical centres

scientific article

Results from the Solithromycin International Surveillance Program (2014).

scientific article published on 4 April 2016

Retrospective molecular analysis of DIM-1 metallo-β-lactamase discovered in Pseudomonas stutzeri from India in 2000.

scientific article published on 21 October 2013

Revised disk diffusion interpretive criteria for cefaclor, loracarbef, cefprozil and cefixime when testing Haemophilus influenzae on haemophilus test medium

scientific article

Revised reference broth microdilution method for testing telavancin: effect on MIC results and correlation with other testing methodologies

scientific article published on 14 July 2014

Revision of linezolid disk diffusion quality control guidelines for testing Staphylococcus aureus ATCC 25923: an independent seven-laboratory trial ⬇️

scientific article published on October 1, 2003

RmtD 16S RNA methylase in epidemiologically unrelated spm-1-producing Pseudomonas aeruginosa isolates from Brazil

scientific article published in April 2008

Rosamicin: in vitro activity comparison with erythromycin and other antibiotics against clinical isolates from the genito-urinary tract and Neisseria meningitidis

scientific article published on September 1979

Roxithromycin in-vitro susceptibility testing of Haemophilus influenzae by NCCLS methods. National Committee for Clinical Laboratory Standards

scientific article published on 01 October 1993

SENTRY antimicrobial surveillance program report: Latin American and Brazilian results for 1997 through 2001.

scientific article

Salmonella bloodstream infections: report from the SENTRY Antimicrobial Surveillance Program (1997-2001).

scientific article published in October 2003

Salmonella spp. isolates causing bloodstream infections in Latin America: report of antimicrobial activity from the SENTRY Antimicrobial Surveillance Program (1997-2000).

scientific article

Sch 29482, a new oral penem: comparative in-vitro activity, beta-lactamase stability and inhibition

scientific article published on 01 February 1982

Selection of a surrogate agent (vancomycin or teicoplanin) for initial susceptibility testing of dalbavancin: results from an international antimicrobial surveillance program

scientific article

Selection of a surrogate beta-lactam testing agent for initial susceptibility testing of doripenem, a new carbapenem

scientific article published on 9 November 2007

Serial sinus aspirate samples during high-dose, short-course levofloxacin treatment of acute maxillary sinusitis

scientific article published in January 2007

Serious streptococcal infections produced by isolates resistant to streptogramins (quinupristin/dalfopristin): case reports from the SENTRY antimicrobial surveillance program

scientific article

Serotype distribution and antimicrobial susceptibility of USA Streptococcus pneumoniae isolates collected prior to and post introduction of 13-valent pneumococcal conjugate vaccine

scientific article published on 24 May 2014

Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumococcal vaccine

scientific article

Serum inhibitory and bactericidal activity of telavancin in non-infected subjects with severe renal impairment or end-stage renal disease

scientific article published on 6 September 2014

Significance of molecular identification and antifungal susceptibility of clinically significant yeasts and moulds in a global antifungal surveillance programme

scientific article published on 13 May 2012

Skin and soft tissue infections in Latin American medical centers: four-year assessment of the pathogen frequency and antimicrobial susceptibility patterns

scientific article

Species identification and determination of high-level aminoglycoside resistance among enterococci. Comparison study of sterile body fluid isolates, 1985-1991

scientific article published on 01 February 1993

Spectrum and activity of three contemporary fluoroquinolones tested against Pseudomonas aeruginosa isolates from urinary tract infections in the SENTRY Antimicrobial Surveillance Program (Europe and the Americas; 2000): More alike than different! ⬇️

scientific article published on November 1, 2001

Spectrum and antimicrobial activity of alexomycin (PNU-82, 127), a peptide compound projected for use in animal health

scientific article

Spectrum and potency evaluation of a new oxazolidinone, linezolid: report from the SENTRY Antimicrobial Surveillance Program, 1998-2000.

scientific article published in May 2002

Spectrum and potency of ceftaroline against leading pathogens causing community-acquired respiratory tract and skin and soft tissue infections in Latin America, 2010.

scientific article published on 31 July 2013

Spectrum and potency of ceftaroline tested against leading pathogens causing community-acquired respiratory tract infections in Europe (2010).

scientific article published on 10 November 2012

Spectrum and potency of ceftaroline tested against leading pathogens causing skin and soft-tissue infections in Europe (2010).

scientific article published on 5 March 2013

Spectrum and potency of dalbavancin tested against 3322 Gram-positive cocci isolated in the United States Surveillance Program (2004).

scientific article published on 19 January 2006

Spectrum of activity, mutation rates, synergistic interactions, and the effects of pH and serum proteins for fusidic acid (CEM-102).

scientific article published in March 2010

Stability of linezolid activity in an era of mobile oxazolidinone resistance determinants: results from the 2009 Zyvox® Annual Appraisal of Potency and Spectrum program ⬇️

scientific article published on December 1, 2010

Standardization of broth microdilution and disk diffusion susceptibility tests for Actinobacillus pleuropneumoniae and Haemophilus somnus: quality control standards for ceftiofur, enrofloxacin, florfenicol, gentamicin, penicillin, tetracycline, tilm

scientific article published on December 1, 2001

Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline

scientific article published on December 1989

Staphylococcus aureus and Coagulase-Negative Staphylococci from Blood Stream Infections: Frequency of Occurrence, Antimicrobial Susceptibility, and Molecular (mecA) Characterization of Oxacillin Resistance in the SCOPE Program ⬇️

scientific article published on March 1, 1998

Statistical criteria for selecting quality control limits for broth microdilution susceptibility tests with 39 different antimicrobial agents. Collaborative Antimicrobial Susceptibility Testing Group

scientific article

Stomatococcus mucilaginosus bacteremias. Typical case presentations, simplified diagnostic criteria, and a literature review

scientific article

Strategic Design of an Effective  -Lactamase Inhibitor: LN-1-255, A 6-ALKYLIDENE-2'-SUBSTITUTED PENICILLIN SULFONE

scientific article

Streptococcus sanguinis isolate displaying a phenotype with cross-resistance to several rRNA-targeting agents

scientific article published on 22 May 2013

Studies to establish quality control ranges for SB-265805 (LB2030) when using National Committee for Laboratory Standards antimicrobial susceptibility test methods. Quality Control Study Group

scientific article published on January 1999

Studies to optimize the in vitro testing of piperacillin combined with tazobactam (YTR 830).

scientific article

Summary of ceftaroline activity against pathogens in the United States, 2010: report from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance program

scientific article published on 2 April 2012

Summary of linezolid activity and resistance mechanisms detected during the 2012 LEADER surveillance program for the United States

scientific article published on 09 December 2013

Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999-2008).

scientific article published in December 2009

Surrogate analysis of vancomycin to predict susceptible categorization of dalbavancin

scientific article published on 7 February 2015

Surveillance for linezolid resistance via the Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) programme (2014): evolving resistance mechanisms with stable susceptibility rates

scientific article published on 23 March 2016

Surveillance in Taiwan using molecular epidemiology for extended-spectrum beta-lactamase-producing Klebsiella pneumoniae

scientific article published in October 2004

Surveillance of JNJ-Q2 activity tested against Staphylococcus aureus and beta-hemolytic streptococci as a component of the 2010 sentry antimicrobial surveillance program ⬇️

scientific article published on 05 October 2011

Surveillance of dalbavancin potency and spectrum in the United States (2012).

scientific article published on 20 February 2013

Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance

scientific article published on 01 April 1999

Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997

scientific article (publication date: September 1999)

Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surve

scientific article published in May 2001

Susceptibility of Klebsiella spp. to colistin and polymyxin B: results from the SENTRY Antimicrobial Surveillance Program (2006–2009) ⬇️

scientific article published on November 30, 2010

Susceptibility of stably derepressed beta-lactamase producing strains to imipenem and four quinolones

scientific article published on 01 February 1988

Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemo

scientific article published on 27 October 2005

Susceptibility patterns of Streptococcus pneumoniae isolates in North America (2002-2003): contemporary in vitro activities of amoxicillin/clavulanate and 15 other antimicrobial agents

scientific article published in April 2005

Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Prog ⬇️

scientific article published on April 1, 2003

Susceptibility rates in Latin American nations: report from a regional resistance surveillance program (2011).

scientific article published on 10 October 2013

Susceptibility testing accuracy of a CTX-M-type extended-spectrum beta-lactamase organism-producing population of Enterobacteriaceae: intermethod analysis for 9 beta-lactams

scientific article published on 4 June 2005

Susceptibility testing interpretive criteria and drug stability for cefdinir, cefetamet, and cefpodoxime against Neisseria gonorrhoeae

scientific article

Susceptibility testing interpretive criteria for levofloxacin when testing respiratory pathogens, Haemophilus influenzae and Moraxella catarrhalis

scientific article published on March 1996

Susceptibility testing of carumonam: interpretive criteria for 30-microgram disk tests and quality control guidelines for disk diffusion and broth microdilution methods

scientific article

Susceptibility to amoxycillin-clavulanate among clinical isolates of Escherichia coli resistant to cefoxitin

scientific article published in February 2006

Susceptibility trends of haemophilus influenzae and Moraxella catarrhalis against orally administered antimicrobial agents: five-year report from the SENTRY Antimicrobial Surveillance Program

scientific article published in September 2003

Sustained activity and spectrum of selected extended-spectrum beta-lactams (carbapenems and cefepime) against Enterobacter spp. and ESBL-producing Klebsiella spp.: report from the SENTRY antimicrobial surveillance program (USA, 1997-2000).

scientific article

Sustained antimicrobial activity of tigecycline against methicillin-resistant Staphylococcus aureus (MRSA) from United States Medical Centers from 2004 through 2008.

scientific article published in February 2010

TR-700 in vitro activity against and resistance mutation frequencies among Gram-positive pathogens

scientific article published on 13 February 2009

Telavancin Activity against gram-positive bacteria isolated from patients with skin and skin-structure infections

scientific article published on October 2010

Telavancin activity against Gram-positive bacteria isolated from respiratory tract specimens of patients with nosocomial pneumonia ⬇️

scientific article published on September 16, 2010

Telavancin activity tested against Gram-positive clinical isolates from European, Russian and Israeli hospitals (2011-2013) using a revised broth microdilution testing method: redefining the baseline activity of telavancin

scientific article published on 10 June 2015

Telavancin activity tested against a collection of Staphylococcus aureus isolates causing pneumonia in hospitalized patients in the United States (2013-2014).

scientific article

Telavancin activity tested against a contemporary collection of Gram-positive pathogens from USA Hospitals (2007–2009) ⬇️

scientific article published on November 10, 2011

Telavancin activity when tested by a revised susceptibility testing method against uncommonly isolated Gram-positive pathogens responsible for documented infections in hospitals worldwide (2011-2013).

scientific article published on 17 January 2015

Telavancin in vitro activity against a collection of methicillin-resistant Staphylococcus aureus isolates, including resistant subsets, from the United States

scientific article published on 5 January 2015

Temafloxacin disk potency and tentative interpretive criteria for susceptibility tests

scientific article published on December 1989

Temocillin: in vitro activity against 734 selected clinical isolates, including beta-lactamase-producing strains

scientific article published on 01 January 1984

Temporal and Geographic Variation in Antimicrobial Susceptibility and Resistance Patterns of Enterococci: Results From the SENTRY Antimicrobial Surveillance Program, 1997-2016

Tentative disk diffusion susceptibility interpretive criteria for BMY-28142, a new cephalosporin.

scientific article published on March 1986

Tentative disk diffusion susceptibility interpretive criteria for pefloxacin

scientific article published on September 1986

Tentative interpretive standards for agar disk diffusion antimicrobial susceptibility testing of cefoperazone ⬇️

scientific article published on May 1, 1982

The Genetic Environment of the cfr Gene and the Presence of Other Mechanisms Account for the Very High Linezolid Resistance of Staphylococcus epidermidis Isolate 426-3147L ⬇️

scientific article published on December 17, 2012

The Importance of Antimicrobial Resistance Monitoring Worldwide and the Origins of SENTRY Antimicrobial Surveillance Program

The Infectious Diseases Society of America's 10 × '20 Initiative (10 New Systemic Antibacterial Agents US Food and Drug Administration Approved by 2020): Is 20 × '20 a Possibility?

scientific article published on 01 June 2019

The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program

scientific article published on 24 June 2019

The North American component (the United States and Canada) of an International Comparative MIC trial monitoring ofloxacin resistance

scientific article published in August 1993

The activity of cefotaxime and desacetylcefotaxime alone and in combination against anaerobes and staphylococci.

scientific article

The activity of daptomycin against wild-type Staphylococcus aureus and strains with reduced susceptibility to vancomycin

scientific article published on 01 September 2006

The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactam

scientific article published in November 1986

The antimicrobial activity of A-56268 (TE-031) and roxithromycin (RU965) against Legionella using broth microdilution method

scientific article published on 01 June 1987

The antimicrobial activity of cephalexin against old and new pathogens

scientific article published on January 1, 1983

The application of in vitro surveillance data for antibacterial dose selection

scientific article

The cefoperazone-sulbactam combination. In vitro qualities including beta-lactamase stability, antimicrobial activity, and interpretive criteria for disk diffusion tests

scientific article published in October 1985

The comparative antimicrobial activity of levofloxacin tested against 350 clinical isolates of streptococci

scientific article published on 01 May 1996

The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study

scientific article published in February 1993

The in vitro activity of sulphones alone and in combination with ampicillin or amoxicillin against Legionella pneumophila and other Legionella spp. including beta-lactamase studies

scientific article published on 01 March 1985

The in vitro evaluation of solithromycin (CEM-101) against pathogens isolated in the United States and Europe (2009) ⬇️

scientific article published on September 8, 2010

The in vitro evaluation of tigecycline tested against pathogens isolated in eight countries in the Asia-Western Pacific region (2008).

scientific article published on 31 March 2010

The prevalence of staphylococcal resistance to penicillinase-resistant penicillins. A retrospective and prospective national surveillance trial of isolates from 40 medical centers

scientific article

Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae

scientific article published in June 2005

Three independent yearly analyses of the spectrum and potency of metronidazole: a multicenter study of 1,108 contemporary anaerobic clinical isolates

scientific article published on 01 February 2001

Tiamulin activity against fastidious and nonfastidious veterinary and human bacterial isolates: initial development of in vitro susceptibility test methods

scientific article

Ticarcillin: a collaborative in vitro comparison with carbenicillin against over 9,000 clinical bacterial isolates

scientific article published on November 1, 1977

Tigecycline (GAR-936) activity against Streptococcus gallolyticus (bovis) and viridans group streptococci

scientific article published on 20 September 2006

Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents

scientific article published in July 2005

Tigecycline activity tested against antimicrobial resistant surveillance subsets of clinical bacteria collected worldwide (2011).

scientific article published on 19 March 2013

Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010-2013).

scientific article published on 23 June 2015

Tigecycline activity tested against multidrug-resistant Enterobacteriaceae and Acinetobacter spp. isolated in US medical centers (2005-2009).

scientific article

Tigecycline antimicrobial activity tested against clinical bacteria from Latin American medical centres: results from SENTRY Antimicrobial Surveillance Program (2011-2014).

scientific article published on 24 May 2016

Tigecycline disk diffusion breakpoints of Acinetobacter spp.: a clinical point of view

scientific article published on June 2007

Timed Kill Kinetic Studies of Levofloxacin, Ofloxacin, and Ciprofloxacin Against Moraxella catarrhalis ⬇️

scientific article published on 01 February 1998

Treatment of Methicillin-Susceptible Staphylococcus aureus Osteoarticular and Prosthetic Joint Infections: Using the Oxacillin Minimum Inhibitory Concentration to Guide Appropriate Ceftriaxone Use ⬇️

scientific article published on March 28, 2013

Trends in Klebsiella pneumoniae carbapenemase-positive K. pneumoniae in US hospitals: report from the 2007-2009 SENTRY Antimicrobial Surveillance Program

scientific article published on 6 May 2013

Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000.

scientific article

Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group

scientific article published in February 2000

Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: report from the SENTRY antimicrobial surveillance programme (2007-09).

scientific article

Trends in gram-positive bloodstream organism resistance: a seven-year audit of five glycopeptides and other drugs at a large university hospital

scientific article published in February 1993

Trends in linezolid susceptibility patterns in 2002: report from the worldwide Zyvox Annual Appraisal of Potency and Spectrum Program

scientific article published in May 2005

Trends in linezolid susceptibility patterns: report from the 2002-2003 worldwide Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program

scientific article published in July 2005

Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States

scientific article published on April 1999

Triazole and echinocandin MIC distributions with epidemiological cutoff values for differentiation of wild-type strains from non-wild-type strains of six uncommon species of Candida

scientific article published on 7 September 2011

Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Species From 1997-2016

Twenty-Year Trends in Antimicrobial Susceptibilities Among From the SENTRY Antimicrobial Surveillance Program

Two investigational glycylcyclines, DMG-DMDOT and DMG-MINO. Antimicrobial activity studies against gram-positive species

scientific article published on 01 January 1996

Two-year assessment of the pathogen frequency and antimicrobial resistance patterns among organisms isolated from skin and soft tissue infections in Latin American hospitals: results from the SENTRY antimicrobial surveillance program, 1997-98. SENTR

scientific article

Typing and molecular characterization of Streptococcus pneumoniae with reduced susceptibility to cefotaxime isolated in Latin America

scientific article published in January 2003

United States resistance surveillance results for linezolid (LEADER Program for 2007).

scientific article

Unmet Needs and Prospects for Oritavancin in the Management of Vancomycin-Resistant Enterococcal Infections ⬇️

scientific article published on April 1, 2012

Unpredictable influence of human serum on antimicrobial activity of erythromycin and three oxime ether macrolides

scientific article published on 01 February 1987

Unpredictable interactions between cefotetan and penicillins or aminoglycosides

scientific article published on 01 September 1984

Update of cefditoren activity tested against community-acquired pathogens associated with infections of the respiratory tract and skin and skin structures, including recent pharmacodynamic considerations

scientific article published on 25 March 2009

Update of contemporary antimicrobial resistance rates across China: reference testing results for 12 medical centers (2011).

scientific article

Update of dalbavancin spectrum and potency in the USA: report from the SENTRY Antimicrobial Surveillance Program (2011).

scientific article published on 26 January 2013

Update of lomefloxacin in vitro activity and spectrum. A multicenter trial testing contemporary pathogens following Food and Drug Administration validation guidelines. Lomefloxacin Activity Study Group

scientific article published in October 1994

Update of the activity of cefditoren and comparator oral beta-lactam agents tested against community-acquired Streptococcus pneumoniae isolates (USA, 2004-2006).

scientific article published in April 2008

Update of the in vitro activity of daptomycin tested against 6710 Gram-positive cocci isolated in North America (2006).

scientific article published on 7 March 2008

Update of the telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2013), when applying the revised susceptibility testing method

scientific article published on 31 December 2014

Update on Acinetobacter species: mechanisms of antimicrobial resistance and contemporary in vitro activity of minocycline and other treatment options

scientific article published on December 2014

Update on antimicrobial susceptibility trends among Streptococcus pneumoniae in the United States: report of ceftaroline activity from the SENTRY Antimicrobial Surveillance Program (1998-2011).

scientific article published on 23 September 2012

Update on dalbavancin activity tested against Gram-positive clinical isolates responsible for documented skin and skin-structure infections in US and European hospitals (2011-13)

scientific article published on 07 October 2015

Update on fusidic acid (CEM-102) tested against Neisseria gonorrhoeae and Chlamydia trachomatis

scientific article published on 26 July 2010

Update on linezolid in vitro activity through the Zyvox Annual Appraisal of Potency and Spectrum Program, 2013.

scientific article published on 2 February 2015

Update on the cefdinir spectrum and potency against pathogens isolated from uncomplicated skin and soft tissue infections in North America: are we evaluating the orally administered cephalosporins correctly?

scientific article published on 12 June 2006

Update on the in vitro activity of daptomycin tested against 17,193 Gram-positive bacteria isolated from European medical centers (2005-2007).

scientific article published in November 2009

Update on the prevalence and genetic characterization of NDM-1-producing Enterobacteriaceae in Indian hospitals during 2010.

scientific article

Update on the telavancin activity tested against European staphylococcal clinical isolates (2009-2010).

scientific article

Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997-2000).

scientific article

Use of Molecular and Reference Susceptibility Testing Methods in a Multicenter Evaluation of MicroScan Dried Overnight Gram-Positive MIC Panels for Detection of Vancomycin and High-Level Aminoglycoside Resistances in Enterococci ⬇️

scientific article published on October 1, 1998

Use of a multiplex PCR to detect and identify Mycobacterium avium and M. intracellulare in blood culture fluids of AIDS patients.

scientific article

Use of a surfactant (polysorbate 80) to improve MIC susceptibility testing results for polymyxin B and colistin ⬇️

scientific article published on October 25, 2012

Use of anidulafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 4,290 clinical isolates of Candida by using CLSI methods and interpretive criteria

scientific article published on 20 June 2014

Use of in vitro susceptibility and pathogen prevalence data to model the expected clinical success rates of tigecycline and other commonly used antimicrobials for empirical treatment of complicated skin and skin-structure infections

scientific article

Use of in vitro vancomycin testing results to predict susceptibility to oritavancin, a new long-acting lipoglycopeptide.

scientific article published on 9 February 2015

Use of micafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 3,764 clinical isolates of Candida by use of CLSI methods and interpretive criteria

scientific article published on 23 October 2013

Use of pharmacodynamic end points in the evaluation of gatifloxacin for the treatment of acute maxillary sinusitis

scientific article

Use of pharmacodynamic endpoints for the evaluation of levofloxacin for the treatment of acute maxillary sinusitis

scientific article published on 3 March 2008

Validation of Etest for seven antimicrobial agents using regulatory criteria for the assessment of antimicrobial susceptibility devices.

scientific article

Validation of NCCLS macrolide (azithromycin, clarithromycin, and erythromycin) interpretive criteria for Haemophilus influenzae tested with the Haemophilus test medium. National Committee for Clinical Laboratory Standards

scientific article

Validation of Sensititre Dry-Form Broth Microdilution Panels for Susceptibility Testing of Ceftazidime-Avibactam, a Broad-Spectrum-β-Lactamase Inhibitor Combination

scientific article published on 26 May 2015

Validation of a commercial dry-form broth microdilution device (Sensititre) for testing tedizolid, a new oxazolidinone

scientific article published on 19 November 2014

Validation of cefditoren MIC quality control ranges by a multi-laboratory study (2001).

scientific article published in May 2001

Validation of commercial dry-form broth microdilution panels and test reproducibility for susceptibility testing of dalbavancin, a new very long-acting glycopeptide

scientific article published in February 2004

Validation of commercial dry-form broth microdilution panels for susceptibility testing of AZD2563, a new long-acting oxazolidinone

scientific article published in June 2003

Vancomycin-resistant Enterococcus raffinosus: Molecular epidemiology, species identification error, and frequency of occurrence in a national resistance surveillance program ⬇️

scientific article published on September 1, 1997

Variability of clarithromycin and erythromycin susceptibility tests with Haemophilus influenzae in four different broth media and correlation with the standard disk diffusion test

scientific article

Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008–2009) ⬇️

scientific article published on September 16, 2010

Variation in potency and spectrum of tigecycline activity against bacterial strains from U.S. medical centers since its approval for clinical use (2006 to 2012).

scientific article published on 3 February 2014

Variations in the Occurrence of Resistance Phenotypes and Carbapenemase Genes Among Isolates in 20 Years of the SENTRY Antimicrobial Surveillance Program

article

Vitek GPS card susceptibility testing accuracy using direct inoculation from BACTEC 9240 blood culture bottles

scientific article published on 01 February 1996

WCK 5222 (Cefepime-Zidebactam) Antimicrobial Activity against Clinical Isolates of Gram-Negative Bacteria Collected Worldwide in 2015.

scientific article published on 27 February 2017

WCK 5222 (cefepime/zidebactam) antimicrobial activity tested against Gram-negative organisms producing clinically relevant β-lactamases

scientific article published on 18 March 2017

WITHDRAWN: Selection of a surrogate beta-lactam testing agent for initial susceptibility testing of doripenem, a new carbapenem

retracted scientific article published on 04 October 2007

Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method

scientific article published on 13 September 2011

Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution

scientific article

Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp.

scientific article published on 18 November 2009

Worldwide antimicrobial susceptibility patterns and pharmacodynamic comparisons of gatifloxacin and levofloxacin against Streptococcus pneumoniae: report from the Antimicrobial Resistance Rate Epidemiology Study Team

scientific article

Worldwide appraisal and update (2010) of telavancin activity tested against a collection of Gram-positive clinical pathogens from five continents

scientific article

Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolates

scientific article

Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999.

scientific article published in May 2001

Worldwide summary of telavancin spectrum and potency against Gram-positive pathogens: 2007 to 2008 surveillance results

scientific article published on 01 August 2010

ZAAPS International Surveillance Program (2007) for linezolid resistance: results from 5591 Gram-positive clinical isolates in 23 countries

scientific article

ZAAPS Program results for 2010: an activity and spectrum analysis of linezolid using clinical isolates from 75 medical centres in 24 countries

scientific article published on December 2012

Zabofloxacin (DW-224a) activity against Neisseria gonorrhoeae including quinolone-resistant strains

scientific article

Zyvox Annual Appraisal of Potency and Spectrum Program Results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from 16 countries

scientific article published in October 2007

Zyvox Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008.

scientific article published in December 2009

Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) program: report of linezolid activity over 9 years (2004-12).

scientific article published on 26 January 2014

[Cephalosporins: 4 generations of structural evolution]

scientific article published on 01 March 1995

[Evaluation of in vitro activity of new fluoroquinolones, cephalosporins and carbapenems against 569 gram-negative bacteria].

scientific article

[In vitro susceptibility testing of 446 clinical isolates of gram-positive bacteria to new quinolones, carbapenems and cephalosporins]

scientific article published on 01 July 1996

blaVIM-2 and blaVIM-7 carbapenemase-producing Pseudomonas aeruginosa isolates detected in a tertiary care medical center in the United States: report from the MYSTIC program.

scientific article published on 6 December 2006

blaVIM-7, an evolutionarily distinct metallo-beta-lactamase gene in a Pseudomonas aeruginosa isolate from the United States

scientific article

β-Lactamase Characterization of Gram-Negative Pathogens Recovered from Patients Enrolled in the Phase 2 Trials for Ceftazidime-Avibactam: Clinical Efficacies Analyzed against Subsets of Molecularly Characterized Isolates

scientific article published on 14 December 2015

Paulina is supported by:

About Paulina

Help